MX2011000780A - Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof. - Google Patents
Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof.Info
- Publication number
- MX2011000780A MX2011000780A MX2011000780A MX2011000780A MX2011000780A MX 2011000780 A MX2011000780 A MX 2011000780A MX 2011000780 A MX2011000780 A MX 2011000780A MX 2011000780 A MX2011000780 A MX 2011000780A MX 2011000780 A MX2011000780 A MX 2011000780A
- Authority
- MX
- Mexico
- Prior art keywords
- plant
- dna construct
- sec
- recombinant dna
- ident
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 187
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 72
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 70
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 69
- 108090000623 proteins and genes Proteins 0.000 title claims description 212
- 241000196324 Embryophyta Species 0.000 claims abstract description 621
- 108020004511 Recombinant DNA Proteins 0.000 claims abstract description 128
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 70
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 70
- 239000002157 polynucleotide Substances 0.000 claims abstract description 70
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 170
- 230000009261 transgenic effect Effects 0.000 claims description 119
- 230000004075 alteration Effects 0.000 claims description 90
- 229910052757 nitrogen Inorganic materials 0.000 claims description 85
- 150000001413 amino acids Chemical class 0.000 claims description 70
- 230000009418 agronomic effect Effects 0.000 claims description 58
- 230000001105 regulatory effect Effects 0.000 claims description 56
- 101710084218 Master replication protein Proteins 0.000 claims description 55
- 101710112078 Para-Rep C2 Proteins 0.000 claims description 55
- 102100022880 Rab proteins geranylgeranyltransferase component A 2 Human genes 0.000 claims description 55
- 101710119961 Trans-acting factor C Proteins 0.000 claims description 55
- 102000004169 proteins and genes Human genes 0.000 claims description 53
- 238000004519 manufacturing process Methods 0.000 claims description 46
- 244000068988 Glycine max Species 0.000 claims description 44
- 239000002773 nucleotide Substances 0.000 claims description 36
- 125000003729 nucleotide group Chemical group 0.000 claims description 35
- 230000007613 environmental effect Effects 0.000 claims description 31
- 230000000295 complement effect Effects 0.000 claims description 26
- 230000012010 growth Effects 0.000 claims description 26
- 235000013399 edible fruits Nutrition 0.000 claims description 20
- 230000001172 regenerating effect Effects 0.000 claims description 19
- 239000002028 Biomass Substances 0.000 claims description 13
- 241001057636 Dracaena deremensis Species 0.000 claims description 13
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 238000003306 harvesting Methods 0.000 claims description 6
- 210000005069 ears Anatomy 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 230000024346 drought recovery Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 abstract description 14
- 210000004027 cell Anatomy 0.000 description 126
- 240000008042 Zea mays Species 0.000 description 117
- 108020004414 DNA Proteins 0.000 description 109
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 109
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 84
- 235000005822 corn Nutrition 0.000 description 84
- 150000007523 nucleic acids Chemical class 0.000 description 75
- 229960005419 nitrogen Drugs 0.000 description 73
- 241000219194 Arabidopsis Species 0.000 description 61
- 230000014509 gene expression Effects 0.000 description 51
- 210000001519 tissue Anatomy 0.000 description 51
- 108091028043 Nucleic acid sequence Proteins 0.000 description 50
- 239000013598 vector Substances 0.000 description 49
- 230000009466 transformation Effects 0.000 description 48
- 235000018102 proteins Nutrition 0.000 description 44
- 239000002609 medium Substances 0.000 description 43
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 40
- 239000002299 complementary DNA Substances 0.000 description 37
- 235000010469 Glycine max Nutrition 0.000 description 32
- 238000004458 analytical method Methods 0.000 description 29
- 210000002257 embryonic structure Anatomy 0.000 description 29
- 239000002679 microRNA Substances 0.000 description 29
- 229940024606 amino acid Drugs 0.000 description 25
- 235000001014 amino acid Nutrition 0.000 description 25
- 102000039446 nucleic acids Human genes 0.000 description 25
- 108020004707 nucleic acids Proteins 0.000 description 25
- 239000013612 plasmid Substances 0.000 description 25
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 23
- 235000009973 maize Nutrition 0.000 description 23
- 238000011161 development Methods 0.000 description 22
- 230000018109 developmental process Effects 0.000 description 22
- 239000012634 fragment Substances 0.000 description 22
- 108700011259 MicroRNAs Proteins 0.000 description 20
- 238000013519 translation Methods 0.000 description 19
- 230000014616 translation Effects 0.000 description 19
- 241000589158 Agrobacterium Species 0.000 description 18
- 238000011282 treatment Methods 0.000 description 18
- 238000005516 engineering process Methods 0.000 description 17
- 108020004999 messenger RNA Proteins 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 16
- 230000001404 mediated effect Effects 0.000 description 16
- 239000002245 particle Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000013604 expression vector Substances 0.000 description 14
- 108091026890 Coding region Proteins 0.000 description 13
- 240000007594 Oryza sativa Species 0.000 description 13
- 235000007164 Oryza sativa Nutrition 0.000 description 13
- 108700019146 Transgenes Proteins 0.000 description 13
- 230000009368 gene silencing by RNA Effects 0.000 description 13
- 241000894007 species Species 0.000 description 13
- 108090000848 Ubiquitin Proteins 0.000 description 12
- 102000044159 Ubiquitin Human genes 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 108091032955 Bacterial small RNA Proteins 0.000 description 11
- 206010020649 Hyperkeratosis Diseases 0.000 description 11
- 108091030071 RNAI Proteins 0.000 description 11
- 238000013459 approach Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 108020004459 Small interfering RNA Proteins 0.000 description 10
- 235000021307 Triticum Nutrition 0.000 description 10
- 241000209140 Triticum Species 0.000 description 10
- 238000003780 insertion Methods 0.000 description 10
- 230000037431 insertion Effects 0.000 description 10
- 238000005215 recombination Methods 0.000 description 10
- 235000009566 rice Nutrition 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 238000013518 transcription Methods 0.000 description 10
- 230000035897 transcription Effects 0.000 description 10
- 241000219195 Arabidopsis thaliana Species 0.000 description 9
- 235000007340 Hordeum vulgare Nutrition 0.000 description 9
- 240000005979 Hordeum vulgare Species 0.000 description 9
- 230000004913 activation Effects 0.000 description 9
- 230000000692 anti-sense effect Effects 0.000 description 9
- 238000004422 calculation algorithm Methods 0.000 description 9
- 238000004520 electroporation Methods 0.000 description 9
- 230000030279 gene silencing Effects 0.000 description 9
- 230000002068 genetic effect Effects 0.000 description 9
- 108091070501 miRNA Proteins 0.000 description 9
- 230000006798 recombination Effects 0.000 description 9
- 239000004055 small Interfering RNA Substances 0.000 description 9
- 108091033380 Coding strand Proteins 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- 244000020551 Helianthus annuus Species 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 101100194343 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rep2 gene Proteins 0.000 description 8
- 230000000408 embryogenic effect Effects 0.000 description 8
- 238000002372 labelling Methods 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 101150117297 rep2 gene Proteins 0.000 description 8
- 230000000392 somatic effect Effects 0.000 description 8
- 230000001629 suppression Effects 0.000 description 8
- 230000017105 transposition Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108091092195 Intron Proteins 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 238000010191 image analysis Methods 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 108010000700 Acetolactate synthase Proteins 0.000 description 6
- 235000003222 Helianthus annuus Nutrition 0.000 description 6
- 230000007022 RNA scission Effects 0.000 description 6
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 6
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 108091060211 Expressed sequence tag Proteins 0.000 description 5
- 244000299507 Gossypium hirsutum Species 0.000 description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 244000062793 Sorghum vulgare Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 210000001161 mammalian embryo Anatomy 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000010152 pollination Effects 0.000 description 5
- 230000002786 root growth Effects 0.000 description 5
- 238000002864 sequence alignment Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229960000268 spectinomycin Drugs 0.000 description 5
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 241000219198 Brassica Species 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- 229920002148 Gellan gum Polymers 0.000 description 4
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 4
- 239000005561 Glufosinate Substances 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- 241000219823 Medicago Species 0.000 description 4
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 4
- 108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000004873 anchoring Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 230000002759 chromosomal effect Effects 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 239000000539 dimer Substances 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000012226 gene silencing method Methods 0.000 description 4
- 230000035784 germination Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 230000035800 maturation Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 230000008488 polyadenylation Effects 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 238000009331 sowing Methods 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- 238000004114 suspension culture Methods 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- 101100194010 Arabidopsis thaliana RD29A gene Proteins 0.000 description 3
- 235000003351 Brassica cretica Nutrition 0.000 description 3
- 240000002791 Brassica napus Species 0.000 description 3
- 235000003343 Brassica rupestris Nutrition 0.000 description 3
- 241000701489 Cauliflower mosaic virus Species 0.000 description 3
- 108091027551 Cointegrate Proteins 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 244000241257 Cucumis melo Species 0.000 description 3
- 101150104463 GOS2 gene Proteins 0.000 description 3
- 244000302512 Momordica charantia Species 0.000 description 3
- 235000009811 Momordica charantia Nutrition 0.000 description 3
- 101001000581 Oryza sativa subsp. japonica Glucose-6-phosphate isomerase, cytosolic A Proteins 0.000 description 3
- 101000893863 Oryza sativa subsp. japonica Glucose-6-phosphate isomerase, cytosolic B Proteins 0.000 description 3
- 235000010582 Pisum sativum Nutrition 0.000 description 3
- 240000004713 Pisum sativum Species 0.000 description 3
- 108700001094 Plant Genes Proteins 0.000 description 3
- 101100194345 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) REP2 gene Proteins 0.000 description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 235000007244 Zea mays Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 3
- 101150102092 ccdB gene Proteins 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 239000003184 complementary RNA Substances 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000021186 dishes Nutrition 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000004720 fertilization Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000001307 helium Substances 0.000 description 3
- 229910052734 helium Inorganic materials 0.000 description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 108091023663 let-7 stem-loop Proteins 0.000 description 3
- 108091063478 let-7-1 stem-loop Proteins 0.000 description 3
- 108091049777 let-7-2 stem-loop Proteins 0.000 description 3
- 108091053735 lin-4 stem-loop Proteins 0.000 description 3
- 108091032363 lin-4-1 stem-loop Proteins 0.000 description 3
- 108091028008 lin-4-2 stem-loop Proteins 0.000 description 3
- 230000000442 meristematic effect Effects 0.000 description 3
- 235000010460 mustard Nutrition 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 235000021232 nutrient availability Nutrition 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 108010054624 red fluorescent protein Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 244000003416 Asparagus officinalis Species 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 235000011293 Brassica napus Nutrition 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 241000723343 Cichorium Species 0.000 description 2
- 240000006740 Cichorium endivia Species 0.000 description 2
- 235000007542 Cichorium intybus Nutrition 0.000 description 2
- 235000015844 Citrullus colocynthis Nutrition 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 235000009091 Cordyline terminalis Nutrition 0.000 description 2
- 244000289527 Cordyline terminalis Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 2
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 208000005156 Dehydration Diseases 0.000 description 2
- 241000173924 Dimorphotheca sinuata Species 0.000 description 2
- 102100040861 G0/G1 switch protein 2 Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 101000893656 Homo sapiens G0/G1 switch protein 2 Proteins 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 229930194542 Keto Natural products 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 239000004201 L-cysteine Substances 0.000 description 2
- 235000013878 L-cysteine Nutrition 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 240000001717 Vaccinium macrocarpon Species 0.000 description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000009390 Vitis sp Nutrition 0.000 description 2
- 241000219096 Vitis sp. Species 0.000 description 2
- 241000482268 Zea mays subsp. mays Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000010310 bacterial transformation Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000003733 chicria Nutrition 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000004634 cranberry Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 239000004062 cytokinin Substances 0.000 description 2
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000013020 embryo development Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 108010050792 glutenin Proteins 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- YKNYRRVISWJDSR-UHFFFAOYSA-N methyl oxirane-2-carboxylate Chemical compound COC(=O)C1CO1 YKNYRRVISWJDSR-UHFFFAOYSA-N 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 239000000618 nitrogen fertilizer Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 101150113864 pat gene Proteins 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000003044 randomized block design Methods 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000021749 root development Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000003584 silencer Effects 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 2
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 229940023877 zeatin Drugs 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- KHWCHTKSEGGWEX-RRKCRQDMSA-N 2'-deoxyadenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 KHWCHTKSEGGWEX-RRKCRQDMSA-N 0.000 description 1
- NCMVOABPESMRCP-SHYZEUOFSA-N 2'-deoxycytosine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 NCMVOABPESMRCP-SHYZEUOFSA-N 0.000 description 1
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
- 101710140048 2S seed storage protein Proteins 0.000 description 1
- 230000005730 ADP ribosylation Effects 0.000 description 1
- 101150001232 ALS gene Proteins 0.000 description 1
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- QGZKDVFQNNGYKY-AKLPVKDBSA-N Ammonia-N17 Chemical compound [17NH3] QGZKDVFQNNGYKY-AKLPVKDBSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 101710117679 Anthocyanidin 3-O-glucosyltransferase Proteins 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 108010037365 Arabidopsis Proteins Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 102100025238 CD302 antigen Human genes 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- 244000292211 Canna coccinea Species 0.000 description 1
- 235000005273 Canna coccinea Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 241000252254 Catostomidae Species 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 101710091838 Convicilin Proteins 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219748 Cyamopsis Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 235000014466 Douglas bleu Nutrition 0.000 description 1
- 102000001388 E2F Transcription Factors Human genes 0.000 description 1
- 108010093502 E2F Transcription Factors Proteins 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 244000127993 Elaeis melanococca Species 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000218218 Ficus <angiosperm> Species 0.000 description 1
- 235000008730 Ficus carica Nutrition 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000178321 Glycine tomentella Species 0.000 description 1
- 108700005087 Homeobox Genes Proteins 0.000 description 1
- 101100273718 Homo sapiens CD302 gene Proteins 0.000 description 1
- 101001109137 Homo sapiens Receptor-interacting serine/threonine-protein kinase 2 Proteins 0.000 description 1
- 101000733257 Homo sapiens Rho guanine nucleotide exchange factor 28 Proteins 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 108700005090 Lethal Genes Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 101100496109 Mus musculus Clec2i gene Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 235000001591 Pachyrhizus erosus Nutrition 0.000 description 1
- 244000215747 Pachyrhizus erosus Species 0.000 description 1
- 235000018669 Pachyrhizus tuberosus Nutrition 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241001442654 Percnon planissimum Species 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 108010047620 Phytohemagglutinins Proteins 0.000 description 1
- 235000008577 Pinus radiata Nutrition 0.000 description 1
- 241000218621 Pinus radiata Species 0.000 description 1
- 235000018999 Pinus serotina Nutrition 0.000 description 1
- 241001139411 Pinus serotina Species 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000017714 Prunus persica var. nucipersica Species 0.000 description 1
- 240000001416 Pseudotsuga menziesii Species 0.000 description 1
- 235000005386 Pseudotsuga menziesii var menziesii Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102100033204 Rho guanine nucleotide exchange factor 28 Human genes 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 108010043934 Sucrose synthase Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- 101710196023 Vicilin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
- 208000005652 acute fatty liver of pregnancy Diseases 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010050181 aleurone Proteins 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 235000000183 arugula Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 101150103518 bar gene Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- HOZOZZFCZRXYEK-GSWUYBTGSA-M butylscopolamine bromide Chemical compound [Br-].C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)CCCC)=CC=CC=C1 HOZOZZFCZRXYEK-GSWUYBTGSA-M 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 108700021031 cdc Genes Proteins 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000014107 chromosome localization Effects 0.000 description 1
- 108010069282 cis-prenyl transferase Proteins 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000012881 co-culture medium Substances 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 101150012655 dcl1 gene Proteins 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000003831 deregulation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000010252 digital analysis Methods 0.000 description 1
- 108020001096 dihydrofolate reductase Proteins 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000006251 gamma-carboxylation Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000004034 genetic regulation Effects 0.000 description 1
- 239000012869 germination medium Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 102000005396 glutamine synthetase Human genes 0.000 description 1
- 108020002326 glutamine synthetase Proteins 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 108010083391 glycinin Proteins 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000007852 inverse PCR Methods 0.000 description 1
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 101150105138 nas2 gene Proteins 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000008775 paternal effect Effects 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000001885 phytohemagglutinin Effects 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 238000000759 time-resolved fluorescence anisotropy Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000010396 two-hybrid screening Methods 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Isolated polynucleotides and polypeptides and recombinant DNA constructs particularly useful for altering root structure of plants, compositions (such as plants or seeds) comprising these recombinant DNA constructs, and methods utilizing these recombinant DNA constructs. The recombinant DNA construct comprises a polynucleotide operably linked to a promoter functional in a plant, wherein said polynucleotide encodes a polypeptide useful for altering plant root architecture.
Description
PLANTS WITH ALTERED RADICULAR ARCHITECTURE, CONSTRUCTOS
RELATED AND METHODS THAT INVOLVE GENES THAT CODIFY FOR REP2 POLIPEPTIDES AND THESE HOMOLOGOS
FIELD OF THE INVENTION
The field of the invention relates to the cultivation and
i
plant genetics and, in particular, is related to
Recombinant DNA constructs useful in plants to alter root architecture.
BACKGROUND OF THE INVENTION
The availability of water and nutrients limits the
i
growth of plants in all, but very few, natural ecosystems. Limit production in most ecosystems
| I
agricultural. The roots of plants play important roles, such as the uptake of water and nutrients, the
i
anchoring of plants; to the soil and the establishment of biotic interactions in the rhizosphere. Therefore, the clarification of the genetic regulation of the development and function of the root of the plant is a subject of considerable interest in agriculture and ecology.
The root system originates from a main root that develops during embryogenesis. The main root produces secondary roots, which in turn produce tertiary roots. All secondary, tertiary, quaternary and other roots are called lateral roots. Many
I
I REF: 216544
i
I
Plants, which include corn, can also produce root suckers, from underground nodules (coronary roots) or superficial nodules! (anchoring roots) consecutive. There are three main processes that affect the overall architecture of the root system. First, cell division in the meristem of the main root allows indeterminate growth by adding new cells to the root.
i
Second, the formation of lateral roots increases the exploratory capacity of the root system. Third, the formation of villi in the roots increases the total surface of the
i
main and lateral roots (Lopez-Bucio et al., Current i
Opinion in Plant Biology (2003) 6: 280-287). Corn mutants have been isolated that lack only one root subgroup.
In Arabidopsis, mutations have been identified in genes of the root structure, such as SHORTROOT and SCARECROW, which show developmental defects of the main and lateral roots, (JE Malamy, Plant, Cell and Environment (2005) 28: 67-77) . :
It has been identified; a large number of corn mutations i
that specifically affected the root development
I
(Hochholdinger, et al., 2004, Annals of Botany 93: 359-368). The recessive mutants rtcs and rtl do not form, or form very few, crowns and anchoring roots, while the main and lateral roots are not affected. In recessive des21 mutants, the lateral seminal roots and the villi of the root are
I
I
they are absent. The villi of the root are absent in the recessive mutant rhul-3. The Irtl and ruml mutants are affected by the initiation of the lateral roots and the slrl and slr2 mutants are affected in the elongation of the lateral roots. The intrinsic response pathways that
I
determine the architecture of the root system include hormones, regulators of the cell cycle and regulatory genes. He
I
Water stress and the availability of nutrients belong to the environmental response pathways that determine the architecture of the root system.
i
The request of 'the United States no. 2005-57473 filed February 14, 2005 (U.S. Patent Publication No. 2005/223429 To published October 6, 2005) relates to the use of cytokinin genes i
Arabidopsis oxidase to alter cytokinin levels
I
in the plants and stimulate the growth of the root.
United States publication no. 6,344,601 (published February 5, 2002) deals with the deficient or excessive expression of prolofilin in a plant cell to alter the growth habit of the plant, for example, a reduced system of root and root villi, retardation
i
at the beginning of flowering.
The patent no. WO2004 / US16432 (registered on May 21
I
of 2004 (Patent No. WO2004 / 106531 published December 9, 2004) deals with the use of methods to manipulate speed j
of growth and / or production and / or architecture by overexpression of the cis-prenyltransferase.
U.S. Patent Application No.
i
2004/489500 filed on September 30, 2004 (publication
í
of U.S. Patent No. 2005/059154 To published on March 13, 2005) is related to methods of modifying the cell number, architecture and performance through the use of over-expression of the transcription factor E2F in plants.
Activation labeling can be used to identify genes with the ability to affect a trait. East
i
The approach has been used in the plant model species Arabidopsis thaliana (Weigel et al., 2000, Plant Physiol. 122: 1003-1013).
The insertions of transcription enhancing elements can, in dominant form, activate and / or increase
I
the expression of nearby endogenous genes.
BRIEF DESCRIPTION OF THE INVENTION
The present invention includes:
In one embodiment, a plant comprising in its genome a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory element, wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% identity of sequence, based on Clustal V alignment method, when compared with sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, I
i
i
31, 33, 35, 37, 39, 41 or 42¡ and where the plant shows alteration in the radicular architecture in comparison with a control plant that does not understand; the recombinant DNA construct.
In another modality: a plant that comprises in its genome
i
a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory element, wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% sequence identity, based on Clustal V alignment method , when compared to sec. with no. Ident.: 15, 17, 19, 21, 23, 25, 27, 29,
31, 33, 35, 37, 39, 41 or 42 and wherein the plant shows an alteration of at least one agronomic characteristic as compared to a control plant that does not comprise the recombinant DNA construct. Optionally, the plant exhibits the
I
alteration of an agronomic characteristic when compared, under variable environmental conditions, where the variable environmental conditions are at least one selected from drought, nitrogen, or disease, with the control plant not comprising the recombinant DNA construct.
In another embodiment, the present invention includes any of the plants, of the present invention, wherein the plant is a corn plant or a soybean plant.
i
In another modality, 1 a method of altering the architecture
¾ I
radiculate in a plant; the method comprises: (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence, wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% sequence identity, based on Clustal V alignment method, when compared to sec. with no. Ident.: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39,
41 or 42; (b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the recombinant DNA construct; and, (c) obtaining a progeny plant derived from the transgenic plant of step (b), wherein the progeny plant comprises in its genome the recombinant DNA construct and shows alteration in the radicular architecture when compared to a control plant that does not include the recombinant DNA construct. !
In another modality, a method to evaluate the radicular architecture in a plant; the method comprises: (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence, wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% sequence identity, based on Clustal V alignment method, when compared to sec. with no. of identical: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39,
41 or 42; (b) regenerating a transgenic plant from cell i
I
regenerable plant after step (a), wherein the transgenic plant comprises in its genome the recombinant DNA construct; (c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the recombinant DNA construct; and (d) evaluate root architecture of the progeny plant compared to
i
a control plant that does not understand the DNA construct i
recombinant.
In another modality, a method to determine the
I
alterations of at least; an agronomic characteristic in a plant; the method comprises: (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operatively linked to at least one sequence
i
regulator, wherein the polynucleotide encodes a polypeptide i
with an amino acid sequence of at least 50% sequence identity, based on Clustal V alignment method, when i
it is compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42; (b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the recombinant DNA construct; (c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the recombinant DNA construct; and (d) determine if the progeny plant shows any alteration of at least one agronomic characteristic.
I
in comparison with a control plant that does not comprise the recombinant DNA construct. Optionally, the determination step (d) comprises determining if the transgenic plant exhibits the alteration of an agronomic characteristic when it is compared, under variable environmental conditions, where the variable environmental conditions are at least one selected
i
of drought, nitrogen, or disease, with the control plant not
i
it comprises the recombinant DNA construct.
i
In another embodiment, the present invention includes an isolated polynucleotide comprising: (a) an acid sequence
i
nucleic acid encoding a polypeptide similar to REP2 or REP2 with one. amino acid sequence of at least 80% sequence identity, when compared to sec. with no. of ident. : 41, i
or at least 85% sequence identity, when compared to sec. with no. of ident .1: 37 or 39, or of at least 95% sequence identity, when compared with sec. with no. Ident .:
17 or 33 based on the method of Clustal V alignment, or a complete complement of the nucleic acid sequence, in which the complete complement and the nucleotide sequence consists of the same number of nucleotides and are 100% complementary. The polypeptides may comprise the amino acid sequence of sec. with no. Ident .: 17, 33, 37, 39 or 41. The nucleotide sequence may comprise the nucleotide sequence of
I
the sec with no. of ident. : 16, 32, 36, 38 or 40
In another embodiment, the present invention relates to
i
a recombinant DNA construct comprising any of the isolated polynucleotides of the present invention operably
linked to at least one regulatory sequence, a cell, a plant, a seed comprising the recombinant DNA construct. '<
BRIEF DESCRIPTION OF THE FIGURES AND LISTINGS OF SEQUENCES
I
The present invention will be more easily understood from the following detailed description and the accompanying figures, as well as from the list of sequences that are part
I
of the present application
Figures 1A-1B show the multiple alignment of the full-length amino acid sequences of the REP2 homologs of sec. with no. Ident .: 15, 17, 29, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39 ', 41 and sec. with no. of ident. : 42
43, 44, 45, 46, and 47. The residues that match the sequence i
Consensus are exactly shaded. The consensus sequence is shown on each alignment. Consensus residues are determined by a clear majority.
Figure 2 shows a table of the percent identity of the sequences and the divergence values for each pair of amino acid sequences of the REP2 homologs that are set forth in Figures 1A-1B.;
Figure 3 is the growth medium that is used for semi-hydroponic maize crops in Example 18.
Figure 4 is a table showing the data related to the effect of different concentrations of nitrate on the growth and development of corn lines derived from Gaspe Bay Flint in Example 18.
The descriptions and the sequence listing attached hereto comply with the rules that determine the descriptions of nucleotide and / or amino acid sequences in applications i
of patent as they are exposed in 37 C.F.R. §1.821-1.825.
The sequence listing contains the single-letter code for the nucleotide sequence characters and the three-letter codes for amino acids as defined in accordance with the IUPAC-IUBMB standards described in Nucleic Acids Res. 13: 3021- 3030 (1985) and Biochemical J. 219 (No. 2j: 345-373 (1984) which are incorporated herein by reference.) The symbols and format used for the nucleotide and amino acid sequence data satisfy with the rules that are set forth in, Title 37 of the CFR, §1.822.
Sec. with no. of i 1dent. : lpHSbarENDs2
1
Sec. with no. of ident. : 2 pD0NR ™ / Zeo
Sec. with no. of ident. : 3 pDONR ™ 221
Sec. with no. of ident. : 4 pBC-yellow
Sec. with no. of ident. : 5 PHP27840
Sec. with no. of ident. : 6 PHP23236
i
Sec. with no. of ident. : 7 PHP10523
Sec. with no. of ident. : 8 PHP23235
Sec. with no. of ídent. : 9 PHP20234
Sec. with no. of ident. : 10 PHP28529
Sec. with no. of ident. : 11 PHP28408
Sec. with no. of i! dent. : 12 PHP22020
Sec. with no. of ident. : 13 PHP29635
Table 1 lists the polypeptides described herein, the designation of the cDNA clones comprising the
I
fragments of nucleic acids encoding polypeptides representing all these polypeptides or a substantial portion thereof, as well as the corresponding identifier (sec. with ident. no .:) as used; in the attached sequence listing.
I
Table 1
Root enhancing proteins (REP)
Protein Designation of clones Sec. With no. Sec. with no.
1 of ident. : from ident :
(Nucleotide) (Amino Acid)
Similar to 14 15
cmstls .pk003; p21a: fis
REP2
Similar to 16 17
my. ctaln.pk0015 bl2
REP2
Similar to 18 19
cfp2n.pk064.114: fis
REP2
Similar to 20 21
cpplc .pk003.123: fis
REP2
Similar to 22 23
ldslc .pk015.17
REP2
Similar to 24 25
dmslc .pkOOl i el6: fis
REP2
I
The sec. with no. of ident. : 42 corresponds to NCBI GI no. :
15241137 (At5gl9590)
The sec. with no. from 'ident. 43 corresponds to NCBI GI no.
115463429 \
The sec. with no. from ident. 44 corresponds to NCBI GI no.
125552383 i
The sec. with no. of ident. 45 corresponds to NCBI GI no. 115438148
The sec. with no. of ident. : 46 corresponds to NCBI GI no.
125533926
The sec. with number. of! ident. : 47 corresponds to NCBI GI no. :
I
118487434 j
The sec. with ident. : 48 is the sequence of i
nucleotides of the "unknown protease" (REP2) (At5gl9590) of
j
Arabidopsis thaliana (coding for the amino acid sequence represented 1 in the sec.with ident.No .: 42, General identifier of NCBI No. 15241137).
The sec. with ID: 49 is the nucleotide sequence of the cDNA encoding the amino acid sequence of the "unknown protein" (REP2) of Arabidopsis thaliana shown in sec. with no. ID: 42, General identifier of NCBI no. 15241137).
The sec. with no. of ident. : 50 is the direct initiator used to introduce the attBl sequence in Example 4.
The sec. with no. of ident. : 51 is the reverse primer used to introduce the attB2 sequence in Example 4.
The sec. with no. ID: 52 is the attBl sequence. The sec. with no. Ident .: 53 is the attB2 sequence.
The sec. with no. Ident: 54 is the direct initiator
i
VC062 in Example 5.
The sec. with no. Ident .: 55 is the reverse primer VC063 in Example 5. I
The sec. with no. ID: 56 PIIOXS2a-FRT87 (ni) m
The sec. with no. of 'ident .: 57 is the AS2 promoter of maize. i
I
I
The sec. with no. of ident. : 58 is the G0S2 promoter.
The sec. with no. j of ident .: 59 is the ubiquitin promoter.
The sec. with no. Ident .: 60 is the S2A promoter. The sec. with no. Ident .: 61 is the PINII terminator.
DETAILED DESCRIPTION OF THE INVENTION
The description of each reference indicated in this
i
it is incorporated herein by reference in its entirety.
As used herein and in the appended claims, the singular forms "a," "an" and "the" include the plural reference unless the context clearly dictates otherwise. Therefore, for example, the reference to "a plant" includes a plurality of such plants, the reference to "a cell" includes one or more cells and the equivalents thereof known to one skilled in the art, etc.
An "expressed sequence tag" ("EST") is a DNA sequence derived from a cDNA library and, therefore, is a sequence that has been transcribed.
i
An EST is obtained, typically, by a single sequencing step of a cDNA insert. The sequence of the entire cDNA insert is called the "complete insert sequence" ("FIS"). A "contig" sequence is an integrated sequence of two or more sequences that can be selected from, but not limited to, the group consisting of an EST, an FIS and a PCR sequence. A sequence that encodes an entire or functional protein is called a "complete gene sequence" ("CGS") and can be derived from an FIS or a you. !
The term "radicular architecture" refers to the arrangement of the different parts: that comprise the root. The terms "radicular architecture", "root structure", "root system" or "root system architecture" are used interchangeably herein.
Generally, the first root of a plant that develops from the embryo is called the main root. In most dicotyledons, the main root is called the stem of the root. This stem of the root grows downward and gives rise to the branched roots (lateral): In the monocotyledons the main root of the plant is branched, to give rise to a fibrous root system.
The term "alteration in the radicular architecture" refers to the aspects of the alterations of the different parts that integrate the root system in different stages of its development in comparison with a reference or control plant. It is understood that the alteration in the radicular architecture covers the alterations in one or more measurable parameters, which include, but are not limited to, the diameter, length, number, angle or surface of one or more parts of the root system, which include, but are not limited to, the main root, the lateral root or branched, adventitial root and root villi, which fall within the scope of the present invention. These changes can cause an alteration altogether in the area or volume occupied by the root. The reference or control plant does not comprise in its genome the recombinant AD construct or heterologous construct.
I
The "agronomic characteristics" are measurable parameters that include, but are not limited to, greenery, yield, growth index, biomass, fresh weight at maturity, dry weight at maturity, fruit production, seed production, total content of nitrogen in the plant, nitrogen content in the fruits, nitrogen content in the seeds, nitrogen content in a vegetative tissue, total content of free amino acids in the plant, content of free amino acids in the fruits, content of free amino acids in the seeds, free amino acid content in a vegetative tissue, total protein content in the plant, protein content in the fruits, protein content in the seeds, protein content in a vegetative tissue, tolerance to drought,
nitrogen uptake, root location, root mass, stem location, plant height, length of spikes
1
and harvest index.
The term stage in! "V" refers to the stages of the leaves of a corn plant; for example, V4 = four, V5 = five leaves with visible collars of leaves. The leaf necklace is the "band" similar to a light colored collar located at the exposed base of a limb, near the point where the limb comes into contact with the stem of the plant. The counting of the leaves begins with the true ho, rounded tip, short and lower and ends
i
with the top sheet with, a visible collar of leaves.
The "rep2", recpu3 and "recpu2" are used interchangeably herein and refer to the locus of Arabidopsis thaliana,
I
At5gl9590 (sec. With ident. ID: 48). The "REP2", RECPU3 and
j
"RECPU2" are used interchangeably herein and refer to the protein (sec., Ident.ident .: 42) encoded by
At5gl9590 (sec. With ident. No .: 48).
"Similar to a rep2" refers to the homologs of the nucleotides of different species, such as corn and soybeans, of the Arabidopsis thaliana "rep2", At5gl9590 (sec. With ident. No .: 48) and includes without limitations any of the nucleotide sequences! of sec. with no. of ident. : 14, 16, 18,
20, 22, 24, 26, 28, 30, 32, 34, 36, 38 or 40.
"Similar to a REP2" refers to protein homologs of different species, such as corn and soybeans, from Arabidopsis thaliana "REP2" (sec. With ident. No .: 42) and includes, without limitations, any of the sequences of amino acids of sec. with no. Ident .: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35,
37, 39 or 41. '
"Environmental conditions" refers to the conditions under which the plant is grown, such as availability I
of water, the availability of nutrients (for example, nitrogen) or the presence of a disease.
"Transgenic" refers to any cell, cell line, callus, tissue, part of the plant or plant, whose genome has been altered by! the presence of a heterologous nucleic acid, such as a recombinant DNA construct, which includes the initial transgenic events as well as those created by sexual crossings! or asexual propagation from the initial transgenic event. As used herein, the term "transgenic" does not encompass the alteration of the conventional genome (chromosomal or extrachromosomal) of plant culture or by natural origin, such as random cross-fertilization, non-recombinant viral infection, non-recombinant bacterial transformation, non-recombinant transposition or spontaneous mutation.
The term "genome", as applied to plant cells, encompasses not only the chromosomal DNA found within the nucleus, but also the organelle DNA found in the subcellular (eg, mitochondrial, plastid) components of the cell.
"Plant" includes everything related to complete plants, plant organs, plant tissues, seeds, plant cells and their progeny. Plant cells include, without limitation, cells, seeds, suspension cultures, embryos, meristematic regions, callus tissue, leaves, roots, shoots, gametophytes, sporophytes, pollen and microspores.
"Progeny" includes any subsequent generation of a plant. ,
"Transgenic" refers to any cell, line
I
cell, callus, tissue, part of the plant or plant, whose genome has been altered by the presence of a heterologous nucleic acid, such as a recombinant DNA construct, which includes the initial transgenic events, as well as those created by sexual crossings or asexual propagation from the initial transgenic event. As used herein, the term
I
"transgenic" does not cover the alteration of the genome (chromosomal or
i
extrachromosomal) by conventional methods of plant culture or by events of natural origin, such as random cross-fertilization, non-recombinant viral infection, non-recombinant bacterial transformation, non-recombinant transposition or spontaneous mutation.
"Transgenic plant" includes that referring to a plant that comprises in its genome a heterologous polynucleotide.
Preferably, the heterologous cleotide poly is integrated
i
stable manner within the genome such that the polynucleotide is transmitted to successive generations. The heterologous polynucleotide: can be integrated into the genome alone or as part of a recombinant DNA construct.
"Heterologous", with respect to a sequence, refers to a sequence that originates from a foreign species or from the same species, is substantially modified from its natural form in composition and / or genomic locus by intentional human intervention. i
The terms "polynucleotide", "nucleic acid sequence", "nucleotide sequence" or "nucleic acid fragment" are used interchangeably and refer to a single or double stranded RNA or DNA polymer that optionally contains synthetic nucleotide bases, not natural or altered. Reference is made to nucleotides (which are usually found in their 51 -monophosphate form) by their designation with a single letter, as follows: "A" for adenylate or deoxyadenylate (for RNA or DNA) , respectively), "C" for i
cycidylate or deoxycytidylate, "G" for guanylate or deoxyguanilate, "U" for uridylate, "T" for deoxythymidylate, "R" for purines (A or G), "Y" for pyrimidines (C or T), "K" for
I
G or T, "H" for A, C or T,; "I" for inosine and "N" for any nucleotide. ,
The terms "polypeptide", "peptide", "amino acid sequence" and "protein" are used interchangeably herein and refer to a polymer of amino acid residues. The terms apply to polymers of amino acids wherein one or more amino acid residues is or is an artificial chemical analogue of a corresponding amino acid of natural origin, as well as polymers of naturally occurring amino acids. The terms "polypeptide", "peptide", "amino acid sequence" and I
"protein" are also inclusive of modifications including, but not limited to, glycosylation, lipid binding, sulfation, gammacarboxylation of glutamic acid residues, hydroxylation and ADP ribosylation.
"Messenger RNA (AR m)" refers to RNA without introns and can be translated into protein through the cell.
"CDNA" refers to a DNA complementary to and synthesized from an mRNA template with the use of the reverse transcriptase enzyme. The cDNA can be single-stranded or can be converted to the double-stranded form with the use of the Klenow fragment of DNA polymerase I.
i
"Mature" protein refers to a posttransitionally processed polypeptide; that is, from where any pre or propeptide present in | the primary translation product was removed.
"Precursor" protein refers to the primary translation product of the mRNA; that is, they still have pre and propeptides present. The pre and propeptides may be, but are not limited to, intracellular localization signals.
"Isolated" refers to materials such as nucleic acid molecules and / or proteins substantially free or
eliminated in some way from the components that normally accompany or interact with the materials in an environment of natural origin. Isolated polynucleotides can be purified from a host cell where they originate naturally. Conventional methods of purification of known nucleic acids can be used for. the experts to obtain isolated polynucleotides. The term also encompasses recombinant polynucleotides and chemically synthesized polynucleotides. |
"Recombinant" refers to an artificial combination of two segments of a sequence separated in some way, for example, by chemical synthesis or manipulation of isolated segments of nucleic acids by genetic engineering techniques. "Recombinant" j also includes that relating to a cell or vector that has been modified by the introduction of a heterologous nucleic acid or a cell derived from an already modified cell, but does not cover alteration of the cell or vector by events of natural origin (for example, spontaneous mutation, transorbination / transduction / natural transposition) such as those that occurred without intentional human intervention. !
"Recombinant DNA construct" refers to a combination of fragments; of nucleic acids that, normally, are not found together [in nature. Therefore, a recombinant DNA construct can comprise regulatory sequences and coding sequences derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different from that found in nature.
i
The terms "input clone" and "input vector" are used interchangeably herein.
"Regulatory sequences" refers to nucleotide sequences located upstream (5 'non-coding sequences), within or | downstream (3 'non-coding sequences) of a coding sequence and influencing the transcription, processing or stability of the RNA or translation of the associated coding sequence. The sequences i
Regulators may include, but are not limited to, promoters, leader translation sequences, introns and polyadenylation recognition sequences. The terms "regulatory sequence" and "regulatory element" are used interchangeably
I
at the moment .
"Promoter" refers to a fragment of nucleic acid with the ability to control the transcription of another fragment of i
nucleic acid. I
"Functional promoter in a plant" is a promoter with the i
ability to control transcription in plant cells, whether or not it originates from a plant cell.
The terms "tissue-specific promoter" and "preferred tissue promoter" are used interchangeably and refer to a promoter that is expressed predominantly, but not necessarily exclusively, in a tissue or organ, but which can also be expressed in a cell specific.
"Developer regulated by development" refers to a promoter whose activity is determined by development events. "Operationally 'linked" refers to the association of nucleic acid fragments in a single fragment so that the function of one is regulated by the function of the other. For example, a promoter is operably linked to a nucleic acid fragment when it can regulate the transcription of that nucleic acid fragment. !
I
The "expression" refers to the production of a functional product. For example, the expression of a nucleic acid fragment can refer to the transcription of the nucleic acid fragment (e.g., the resulting transcription in AR m or functional RNA) and / or the translation of mRNA into a precursor or mature protein.
"Phenotype" refers to the perceptible characteristics of a cell or organism.
"Introduced", in the context of inserting a nucleic acid fragment (e.g., a recombinant DNA construct) into a cell, means "transiation", "transformation" or "transduction" and includes reference to the incorporation of a fragment of nucleic acid in a eukaryotic or prokaryotic cell, wherein the nucleic acid fragment can be incorporated into the genome of the cell (e.g., chromosomal, plasmid, plastid or mitochondrial DNA), converted into a self-contained or transiently expressed replicon (e.g. example, transfected mRNA).;
A "transformed cell" is any cell in which a nucleic acid fragment has been introduced (e.g., a construct of reclosing DNA).
"Transformation," as used in the present, refers to both stable and transient transformation.
"Stable transformation" refers to the transfer of a nucleic acid fragment to a genome of a host organism that produces a genetically stable inheritance. Once stably transformed, the nucleic acid fragment is stably integrated into the genome of the host organism and any subsequent generation.
"Transient transformation" refers to the introduction of a nucleic acid fragment in the nucleus, or organelle containing DNA, of a host organism that results in gene expression without genetically stable inheritance.
The "allele" is one of several alternative forms of a gene that occupies a particular locus on a chromosome. When the alleles present in a locus given in a pair of homologous chromosomes in a diploid plant 1 are equal, that plant is homozygous for that locus. If the alleles present in a given locus in one of a pair of homologous chromosomes in a diploid plant differ, that plant is heterozygous for that locus. If a transgene is present in one of a pair of homologous chromosomes in a diploid plant, that plant is hemicigota for that locus.
The sequence alignments j and percent identity calculations can be determined by various comparison methods 1 designed to detect homologous sequences that include, but are not limited to, the Megalign® program of the integrated LASERGENE® bioinformatics package (ADNSTAR® Inc., Madison, WI). Unless indicated otherwise, multiple alignments of the sequences provided herein were made with the use of the Clustal V alignment method (Higgins and Sharp (1989) CABIOS 5: 151-153) with the predetermined parameters (PENALIZATION OF INTERRUPTION = 10, PENALTY OF LENGTH OF INTERRUPTION10). The default parameters for alignments in pairs and for the calculation of the percent identity of protein sequences with the Clustal V method are KTUPLE = 1, PENALTY OF INTERRUPTION3, WINDOW = 5 and DIAGONALS SAVED = 5. For nucleic acids, these parameters are KTUPLE = 2, PENALTY OF INTERRUPTION5, WINDOW = 4 and DIAGONALS SAVED =. After aligning the sequences with the Clustal V program it is possible to obtain values of "percentage of identity" and
"divergence" when observing; the "sequence distances" table in the same program; Unless stated otherwise, the percentages of identity and divergences provided and claimed herein were calculated in this manner.
The standard techniques of recombinant DNA and molecular cloning used herein are well known in the art and are described in more detail in Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter "Sambrook").
Now, regarding the preferred modalities:
Preferred embodiments include isolated polynucleotides and recombinant DNA constructs, compositions (such as plants or seeds) comprising the recombinant DNA constructs and methods using these recombinant DNA constructs.
Isolated Polynucleotides and Preferred Polypeptides The present invention includes the following isolated polynucleotides; and preferred polypeptides:
An isolated polynucleotide comprising: (i) a nucleic acid sequence encoding a polypeptide with an amino acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57% , 58%, 59%, 60,%, 56 ¾, 62%, 63%, 64%, 65%, 66%,
i
67, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82,%, 83 %, 84, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100 % sequence identity, based on Clustal V alignment method, when compared to sec. with no. Ident .: 15, 17, 19, 2l, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42; or (ii) a total complement of the nucleic acid sequence of (i). Any of the above-mentioned isolated polynucleotides can be used in any recombinant DNA construct (including the suppressor DNA constructs) of the present invention. The polypeptide is preferably a REP2 or protein similar to a REP2.
An isolated polypeptide with an amino acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57
1
58%, 59%, 60%, 56%, 62 | %, 63%, 64%, 65%, 66%, 67%, 68%
69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79
80%, 81%, 82%, 83%, 84.%, 85%, 86%, 87%, 88%, 89%, 90%
91%, 92%, 93, 94%, 95%, 96%, 97%, 98%, 99% OR 100% d < sequence identity,, based on alignment method
Clustal V, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42. The polypeptide is preferably a REP2 or protein similar to a REP2.
An isolated polynucleotide comprising (i) a nucleic acid sequence of at least 50, 51, 52%, 53, 54%
55%, 56 57% (58%, 59 (%, 60%, 56 62 63%, 64%, 65
66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76
77%, 78 79%, 80%, 81%, 82%, 83 84%, 85%, 86 87%
88%, 89%, 90%, 91%, 921%, 93%, 94%, 95%, 96%, 97 98% 99% or 100% sequence identity, based on the Clustal V alignment method when compare with sec. with no. of ident: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40 or 49, or (ii) a total complement of the nucleic acid sequence of (i) ). Any of the isolated polynucleotides mentioned above can be used in any DNA construct
i
recombinant (including the DNA suppressor constructs) of the present invention. The isolated polynucleotide encodes a REP2 or a protein similar to a: REP2.
Constructs of recombinant DNA and DNA constructs
I
suppressor preferred.
In one aspect, the present invention includes recombinant DNA constructs (including DNA suppressor constructs).
In a preferred embodiment a recombinant DNA construct comprises a polynucleotide operably linked to at least one regulatory sequence (eg, a functional promoter in a plant), wherein the polynucleotide comprises (i) a nucleic acid sequence encoding a amino acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 56%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80% 81% 82% 83% 84% 85% 86% 88% 89% 90% 92% 93% 94% 96% 97%, 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to sec. with no.
i
of ident: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42, or (ii) a total complement of the nucleic acid sequence of (i) ). !
In another preferred embodiment, a recombinant DNA construct comprises a: polynucleotide operably linked to at least one regulatory sequence (eg, a functional promoter in a plant), wherein the polynucleotide comprises (i) a nucleic acid sequence of at least 50%, 51%,
52%, 53%, 54%, 55%, 56; %, 57%, 58%, 59%, 60%, 56%, 62%
63%, 64"o / 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%
74%, 75, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%
85%, 86 or 87 o.
or / 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%
96"5 97%, 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to sec.
í
with no. of ident. : 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40 or 49 or (ii) a total complement of the nucleic acid sequence of (i).
Figures 1A-IB, show the multiple alignment of the amino acid sequences of sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29 ^, 31, 33, 35, 37, 39 and 41 and of the sec. with no. Ident .: 42, 443, 44, 45, 46 and 47. Multiple sequence alignment was performed with the use of the Megalign® program of the integrated LASERGENE® bioinformatics package (ADNSTAR® Inc., Madison, WI); Particularly, with the use of the Clustal V alignment method (Higgins and Sharp (1989) CABIOS 5: 151-153) with: the default parameters of the multiple alignment of PENALTY OF INTERRUPTION = 10 and PENALTY OF INTERRUPTION LENGTH = 10 and the default parameters of the alignment in pairs of KTUPLE = 1, PENALTY OF INTERRUPTION3, WINDOW = 5 and DIAGONAL
I SAVED = 5.
Figure 2 shows the percentage of sequence identity and divergence values for each pair of amino acid sequences, which are presented in Figures 1A-1B.
In another preferred embodiment, a recombinant DNA construct comprises a polynucleotide operably linked to at least one regulatory sequence (e.g., a functional promoter in a plant), wherein the polynucleotide encodes a
REP2 or protein similar to a REP2.
In another aspect, the present invention includes suppressor DNA constructs.
A suppressor DNA construct preferably comprises at least one regulatory sequence (preferably, a promoter i).
functional in a plant) ique is operationally (a) fully or partially bound to (i) a nucleic acid sequence encoding a polypeptide with an amino acid sequence of at least
50%, 51%, 52%, 53%, 54; %, 55%, 56%, 57%, 58%, 59%, 60%,
1
56%, 62%, 63%, 64%, 65,%, 66%, 67%, 68%, 69%, 70%, 71,
72 73%, 74%, 75%, 76, 77%, 78%, 79%, 80%, 81%, 82%,
83%, 84%, 85%, 86%, 87! 88%, 89%, 90%, 91%, 92%, 93%,
94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42o (ii) a total complement of the nucleic acid sequence of (a) (i); or (b) a region derived from all or part of a sequencer or non-coding strand of a target gene of interest; the region with a nucleic acid sequence of at least 50%, 51%,
52 or 53 54 55%, 56%, 57%, 58 or r 59%, 60%, 56%, 62%
63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%
74%, 75%, 76%, 77%, go; %, 79%, 80% / 81%, 82%, 83%, 84%
85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%
96 o
° / 97 o.
| 5/98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to all or part of a sequencer or non-coding chain from which the region is derived and in which the target gene of interest encodes a REP2 or protein similar to a
REP2; or (c) in whole or in part to (i) a nucleic acid sequence of at least 50%, 51%, 52%, 53% / 54%, 55%, 56%,
57%, 58%, 59%, 60%, 56%, 62%, 63%, 64%, 65%, 66%, 67%,
68"or 69 * ¾> / 70%, 71%, 72 o.
¾ / 73%, 74%, 75%, 76%, 77%, 78%,
79%, 80% (81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%,
90%, 91%, 92%, 93%, 94 o,
"o / 95%, 96%, 97%, 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to the sec. with ID number: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40 or 49, or (ii) a total complement of the nucleic acid sequence of (c) (i).
The suppressor DNA construct preferably comprises an i
cosupressor construct, antisense construct, virus suppressor construct, hairpin suppressor construct, stem-loop suppressor construct, double-stranded RNA producer construct, RNAi construct or small RNA construct (e.g., a construct of AR ip or a construct of miRNA).
It is understood, as will be appreciated by those skilled in the art, that the invention encompasses other sequences in addition to the specific illustrative sequences. Alterations of a nucleic acid fragment that result in the production of a chemically equivalent amino acid at a given site but do not affect the functional properties of the encoded polypeptide are well known in the art. For example, a codon for the amino acid alanine, a hydrophobic amino acid, can be replaced by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine or isoleucine. Similarly, changes can also be expected resulting in the substitution of a negatively charged residue for another, such as aspartic acid for glutamic acid, or a positively charged residue for another, such as lysine for arginine, to produce a functionally equivalent product. In addition, no nucleotide changes are expected resulting in alteration of the N-terminal and C-terminal portions of the polypeptide molecule to alter the activity of the polypeptide. Each of the proposed modifications remains within the routine of the technique, as does the determination of the retention of the biological activity of the encoded products.
"Suppressor DNA construct" is a recombinant DNA construct that, when transformed or stably integrated into the plant genome, results in the "silencing" of a target gene in the plant. The target gene can be endogenous or transgenic to the plant. Jump up ^ "Silencing", as used herein with respect to: target gene, refers, in general, to the levels of mRNA or protein / enzyme deletion expressed by the target gene and / or the level of enzymatic activity or of protein functionality. The term "suppressor" includes lowering, reducing, declining, decreasing, inhibiting, eliminating or preventing. "Silencing" or "gene silencing" does not specify the mechanism and is inclusive and is not limited to antisense, cosuppression, viral suppression, hairpin suppression, stem-loop suppression, RNAi-based approaches and small RNA-based approaches.
A suppressor DNA construct can comprise a region derived from a target gene of interest and can fully or partially comprise the nucleic acid sequence of the sense strand (or antisense strand) of the target gene of interest. Depending on the approach used, the region can be 100% identical or less than 100% identical (for example, at least 50%, 51%,
52 q,
¾ / 53%, 54%, 55, 56,%, 57%, 58%, 59%, 60%, 56%, 62%,
63 or 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71, 72%, 73%,
74%, 75 or 76 o / 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%,
85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%,
96%, 97%, 98%, 99% identical) to all or part of the chain in the sense (or antisense chain) of the gene of interest.
Suppressor DNA constructs are well known in the art, they are easily constructed once the target gene of interest is selected and include, but are not limited to, cosuppressor constructs, antisense constructs, viral suppression constructs, hairpin suppressor constructs, constructs stem-loop suppressors, double-stranded RNA producing constructs and, more generally, RNAi (interfering RNA) constructs and small RNA constructs such as RNAip constructs (short interfering RNA) and miRNA constructs (microRNA).
"Antisense inhibition" refers to the production of antisense DNA transcripts with the ability to suppress the expression of the protein. { objective .
"Antisense RNA" refers to an RNA transcript complementary to all or a portion of a primary transcript or target mRNA and which blocks the expression of an isolated fragment of target nucleic acid (U.S. Patent No. 5, 107, 065) ). The complementarity of an antisense RNA can be with any portion of the specific genetic transcript, ie, in the 5 'non-coding sequence, 3' non-coding sequence, introns or coding sequence.
"Cosuppression" refers to the production of sense RNA transcripts with the ability to suppress the expression of the target protein. "Sense" RNA refers to the RNA transcript that includes the mRNA and what can be translated into protein within a cell or in vi'tro. Previously, cosupressor constructs have been designed in plants focusing on the overexpression of a nucleic acid sequence with homology to a native mRNA, in sense orientation, which results in the reduction of all RNA with homology to the overexpressed sequence (see Vaucheret et al. (1998) Plant J. 16: 651-653; and Gura (2000) Nature 404: 804-808).
Another variation describes the use of viral sequences in plants to direct suppression of the proximal mRNA encoding sequences (PCT Publication No. WO 98/36083 published August 20, 1998),
The use of "hairpin" structures incorporating all or part of an mRNA encoding the sequence in a complementary orientation resulting in a potential "stem-loop" structure for the expressed RNA has been previously described (PCT publication No. WO. 99/53050 published October 21, 1999). In this case, 1 the stem is formed by the polynucleotides corresponding to the gene of interest inserted in the sense or antisense orientation with respect to the promoter and the loop is formed by some polynucleotides of the gene of interest that does not have a complement in the construct. In this way, the frequency of the cosuppression or the silencing in the transgenic plants recovered is increased. To review the suppression of forks see Wesley, S.V. et al. (2003) methods in Molecular Biology, Plánt Functional Genomics: Methods and Protocols 236: 273-286.
A construct in which the stem is formed of at least 30 nucleotides of a gene to be deleted and the loop is formed by a random nucleotide sequence (PCT publication No. WO 99/61632 published on December 2) has also been used for suppression. of 1999).
The use of poly-T and poly-A sequences to generate the stem in the stem-loop structure has also been described (PCT Publication No. WO 02/00894 published on January 3, 2002).
Another variant includes the use of synthetic repeats to promote the formation of a stem in the stem-loop structure. The transgenic organisms prepared with the recombinant DNA fragments have been shown to have reduced levels of the protein encoded by the nucleotide fragment forming the loop, as described in PCT publication no. WO 02/00904 published on January 3, 2002.
Interference RNA refers to the process of post-transcriptional gene silencing of sequence in animals mediated by short interfering RNA (siRNA) (Fire et al., [Nature 391: 806 1998). The corresponding process in plants is commonly referred to as posttranscriptional gene silencing (SGPT) or RNA silencing, as well as fungal suppression. It is believed that the process of posttranscriptional gene silencing is an evolutionarily conserved cell defense mechanism used to prevent gene expression
1
foreign and commonly shared by various floras and phyla (Fire et al., Trends Genet 15: 358-1999). Perhaps such protection of foreign gene expression has evolved due to the production of double-stranded RNA (dsRNA) derived from viral infection or the random integration of transposon elements into a host genome by a cellular response that specifically destroys the single-stranded RNA RNA homolog viral genomic The presence of dsRNA in the cells triggers the response of the RNAi by a mechanism that has not yet been fully characterized.
The presence of long dsRNA in the cells stimulates the activity of a kidney III enzyme called a dimer. The dícer participates in processing the dsRNA in small parts of dsRNA
I
known as short interfering RNA (siRNA) (Berstein et al.
al., Nature 409: 363 20 ??). Typically, short RNAs from
I
interference that derive from the activity of dícer have of i
about 21 to about 23 nucleotides in length and comprise approximately 19 base pair duplexes (Elbashir et al., Genes Dev. 15: 188 2001). Dicer also participates in the elimination of small 21 and 22 nucleotide temporal RNAs (tRNAs) from the precursor RNA of conserved structure that are part of the translation control (Hutvagner et al., 2001, Science 293: 834,). The RNAi response also consists of an endonucleases complex, commonly called an RNA-induced silencing complex (RISC), which regulates the cleavage of single-stranded RNA with sequence complementarity with the antisense strand of the siRNA duplex. The cleavage of the target RNA is carried out in the middle of the region complementary to the antisense strand of the siRNA pair (Elbashir et al., Genes Dev. 15: 188 2001). In addition, interfering RNA may also require small RNA (for example, miRNA) mediated by gene silencing, probably through cellular mechanisms that regulate the chromatin structure and thus prevent transcription of target gene sequences (see, for example, Allshire, Science 297: 1818-18192002, Volpe et al., Science 297: 1833-1837 2002, Jenuwein, Science 297: 2215-2218 2002, and Hall et al., Science 297: 2232-2237 2002). Thus, the miRNA molecules of the invention can be used to regulate gene silencing by interacting with RNA transcripts or, alternatively, by interacting with particular genetic sequences, where the interaction results in gene silencing, either at the transcriptional or post-transcriptional level.
RNAi has been studied in a variety of systems. Fire et al. (Nature 391: 80; 61998) were the first to observe RNAi enC. elegans Wianny and Goetz (Nature Cell Biol. 2: 701999) describe RNAi mediated by dsRNA in mouse embryos. ond et al. (Nature 404: 293 2000) describe the RNAi in fruit fly cells transfected with dsRNA. Elbashir et al., (Nature 411: 494 2001) describe the RNAi induced by the introduction of 21-nucleotide synthetic RNA pairs into cells of cultured mammals including human embryonic kidney cells and HeLa cells.
Small RNAs play an important role in the control of gene expression. The regulation of several development processes, including flowering, is controlled by small RNAs. Now it is possible to create changes in the genetic expression of plant genes through the use of transgenic constructs that produce small RNAs in the plant.
Apparently, small RNAs work by base pairing with complementary RNA or target DNA sequences. When binding with RNA, small RNAs drive either the cleavage of the RNA or the inhibition of translation of the target sequence. By binding to target DNA sequences, it is thought that small RNAs can mediate DNA methylation of the target sequence. The consequence of these events, regardless of the specific mechanism, is that genetic expression is inhibited.
It is thought that the complementarity of sequences between
Small RNAs and their target RNAs help determine what mechanism, RNA cleavage or translation inhibition is used. It is thought that siRNAs, which are perfectly complementary to their targets, work by RNA clone. Some miRNAs have a perfect or almost perfect complementarity with their targets and RNA cleavage has been demonstrated for at least some of these miRNAs. Other miARs have several differences with their objectives and, apparently, inhibit their objectives at the level of translation. Again, without being subject to a particular theory about the 'mechanism of action, a general rule emerges, that perfect or near-perfect complementarity causes RNA cleavage, whereas inhibition of translation is favored when the pair of miRNAs / Obj etivo contains several differences. The apparent exception to this is microRNA 172 (miR172) in plants. One of the targets of miR172 is APETALA2 (AP2) and although miR172 shares an almost perfect complementarity with AP2 it seems to cause inhibition of AP2 translation rather than RNA cleavage.
MicroRNAs (miRNA) are non-coding RNAs of about 19 to about 24 nucleotides (nt) in length that have been identified in both animals and plants (Lagos-Quintana et al., Science 294: 853-8582001, Lagos-Quintana et al. al., Curr. Biol. 12: 735-739 2002; Lau et al., Science 294: 858-8622001; Lee and Ambros, Science 294: 862-8642001; Llave et al., Plant Cell 14: 1605-1619 2002; Mourelatos et al., Genes, Dev 16: 720-7282002, Park et al., Curr. Biol. 12: 1484-14952002, Reinhart et al., Genes., Dev. 16: 1616-1626 2002). These are processed from precursor transcripts longer than in size ranging from about 70 to 200 nt and these precursor transcripts have the ability to form stable hairpin structures. In animals, the enzyme involved in the processing of miRNA precursors is called dimer, a protein similar to RNAse III (Grishok et al., Cell 106: 23-34 2001; Hutvagner et al., Science 293: 834-8382001 Ketting et al., Genes, Dev. 15: 2654-26592001). The plants also have an enzyme similar to the dimer, DCL1 (formerly called CARPEL FACTORY / SHORT INTEGUMENTS1 / SUSPENSOR1) and recent evidence indicates that it, like the dimer, is involved in the processing of hairpin precursors to generate mature miRNAs. (Park et al., Curr. Biol. 12: 1484-1495 2002; Reinhart et al., Genes. Dev. 16: 1616-1626 2002). In addition, it has been clarified with recent research that at least some miRNA precursors originate as longer polyadenylated transcripts, and various miRNAs and associated hairpins may be present in a single transcript (Lagos-Quintana et al., Science 294: 853-8582001; Lee et al., EMBO J 21: 4663-46702002). Recent studies also analyzed the selection of the miRNA chain of the dsRNA product, which arises from the DICER processing of the fork (Sch artz et al., 2003; Cell 115: 199-208). It seems that
i
stability (ie, the content of G: C vs. A: U and / or the differences) of the two ends of the processed dsRNA affects the selection of the chains, with the low stability end easier to unwind by the activity of a helicase The 5 'end chain is incorporated into the RISC complex at the low stability end, while the other chain is degraded.
MicroRNAs seem to regulate target genes by binding to complementary sequences located in the transcripts produced by these genes. In the case of lin-4 and let-7, the target sites are located in the 3 'UTR of the target mRNAs (Lee et al., Cell 75: 843-854-1993, - Wightman et al., Cell 75: 855- 8621993; Reinhart et al., Nature 403: 901-9062000; Slack et al., Mol.Cell 5: 659-669 2000) and there are: many differences between the miRNAs of lin-4 and let-7 and their target sites. The binding of the miRNA of lin-4 or let-7 appears to cause down-regulation of the stable levels of the protein encoded by the target mRNA without affecting the transcript itself (Olsen and Ambros, Dev. Biol. 216: 671-6801999). On the other hand, recent evidence suggests that miRNA may, in some cases, elicit the specific RNA of the target transcript within the target site, and this cleavage step requires 100% complementarity between the miRNA and the target transcript. (Hutvagner and Zamore, Science 297: 2056-20602002; Llave et al., Plant Cell 14: 1605-1619 2002). It seems likely that miRNAs can enter at least two pathways of target gene regulation: protein deregulation when the target complementarity is < 100% and RNA cleavage when the objective complementarity is 100%. MicroRNAs that enter the RNA cleavage pathway are analogous to short interfering RNA (siRNA) of 21-25 nt generated during RNA interference (iRNA) in animals and posttranscriptional gene silencing (SGPT) in plants (Harailton and Baulcombe 1999; Hammond et al., 2000; Zamore et al., 2000; Elbashir et al., 2001) and, probably, are incorporated in an AR-induced silencing complex (RISC) similar or identical to observed for RNAi.
The identification of the objectives of miRNA with bioinformatics has not been successful in animals and this is probably due to the fact that the animal miRNA has a low degree of complementarity with its objectives. On the other hand, approaches with bioinformatics have been used successfully to predict targets for plant miRNA (Llave et al., Plant Cell 14: 1605-1619 2002; Park et al., Curr. Biol. 12: 1484-1495 2002; Rhoades et al., Cell1110: 513-5202002) and, therefore, it appears that miRNAs in plants have greater complementarity in conjunction with their putative targets than miRNAs in animals. The majority of these target miRNA transcripts in plants encode family members of the transcription factor involved in the structure of cell growth or differentiation in plants.
A recombinant DNA construct (including a suppressor DNA construct) of the present invention preferably comprises at least one regulatory sequence.
A preferred regulatory sequence is a promoter.
A wide variety of promoters can be used in the recombinant DNA constructs (and the DNA constructs)
suppressor) of the present invention. The promoters can be selected based on the desired result and can include constitutive, tissue-specific, cellular-specific, inducible or other promoters for expression in the host organism.
High level constitutive expression of the candidate gene under control of the 35S or UBI promoter can have pleiotropic effects, although the efficacy of the candidate gene can be determined when driven by a constitutive promoter.
The use of a specific expression for tissue and / or stress can eliminate unwanted effects but retain the ability to alter the root architecture. This effect has been observed in Arabidopsis (Kasuga et al. (1999) Nature Biotechnol 17: 287-291) /
Suitable constitutive promoters for use in a plant host cell include, for example, the core promoter of the Rsyn7 promoter and other constitutive promoters described in patent no. O 99/43838 and the patent of the
United States no. 6, 072 !, 050; the CaMV 35S core promoter (Odell et al., Nature 313: 810-812 (1985)); rice actin (McElroy et al., Plant Cell 2: 163-171 (1990)); ubiquitin (UBI) (Christensen et al., Plant Mol. Biol. 12: 619-632 (1989) and Christensen et al., Plant Mol. Biol. 18: 675-689 (1992)); pEMU (Last et al., Theor, Appl. Genet, 81: 581-588 (1991)); MAS (Velten et al., EMBOJ. 3: 2723-2730 (1984)); ALS promoter (U.S. Patent No. 5,659,026), the corn G0S2 promoter (Patent No. WO0020571 A2 published April 1, 2000) and the like. Other constituent promoters include, for example, those mentioned in United States Patent Nos. 5,608,149; 5,608,144; 5,604,121; 5,569,597; 5,466,785; 5,399,680; 5,268,463; 5,608,142 and 6,177,611.
In selecting a promoter for use in the methods of the invention, a tissue-specific or development-regulated promoter may be preferred.
A preferred promoter specific for tissue or regulated by development is a DNA sequence that regulates the expression of a DNA sequence selectively in the cells / tissues of a plant, critical for the development of the panicle, seeds or both and limits the expression of the DNA sequence to the period of development of the panicle or to the maturation of the seeds in the plant. Any identifiable promoter that causes the desired temporal and spatial expression can be used in the methods of the present invention.
Seed or embryo-specific promoters which may be useful in the invention include the Kunitz-trisin inhibitor of soybeans (Kti3, Jofuku and Goldberg, Plant Cell 1: 1079-1093 (1989)), patatin (tubers of papa) (Rocha-Sosa, M., et al. (1989) EMBO J. 8: 23-29), convicilin, vicilin and legume (cotyledons of peas) (Rerie, WG, et al. (1991) Mol. Genet 259: 149-157; Newbigin, EJ, et al. (1990) Plant 180: 461-470; Higgins, TJV, et al. (1988) Plant Mol. Biol. 11: 683-695), zein (corn endosperm) (Schemthaner, JP, et al. (1988) EMBO J. 7: 1249-1255), phaseolin (bean cotyledons) (Segupta-Gopalan, C, etal. (1985) Proc. Nati. Acad. Sci United States; 82: 3320-3324), phytohemagglutinin (bean cotyledons) (Voelker, T. et al. (1987) EMBO J. 6: 3571-3577), B-conglycinin and glycinin (soybean cotyledon) ) (Chen, ZL, et al .: (1988) EMBO J. 7: 297-302), glutelin (rice endosperm), hordein (endosperm of barley) (Marris, C, et al. (1988) Plant, Mol. Biol. 10: 359-366), glutenin and gliadin (wheat endosperm) (Colot, V., et al. (1987) EMBO J. 6: 3559-3564) and sporamin (tuberous sweetpotato root) (Hattori, T ., et al. (1990) Plant Mol. Biol. 14: 595-604). Promoters of seed-specific genes operably linked to heterologous coding regions in chimeric gene constructs maintain their temporal and spatial expression structure in tr, ansgenic plants. Such examples include the 2S seed storage protein promoter of Arabidopsis thaliana to express enkephalin peptides in seeds of Arabidopsis and Brassica napus (Vanderkerckhove et al., Bio / Technology 7: L929-932 (1989)), lecithin promoters. bean and beta-phaseolin from bean to express luciferase (Riggs et al., Plant Sci. 63: 47-57 (1989)) and wheat glutenin promoters to express chloramphenicol acetyltransferase (Colot et al., EMBO J 6: 3559 - 3564 (1987)).
Inducible promoters selectively express an operably linked DNA sequence in response to an endogenous or exogenous stimulus, for example, by chemical compounds (chemical inducers) or in response to environmental, hormonal, chemical and / or developmental signals. The inducible or regulated promoters include, for example, promoters regulated by light, heat, stress, flood or drought, phytohormones, lesions, or chemical substances, such as ethanol, jasmonate, salicylic acid or protective substances.
Preferred promoters include the following: l) the stress-inducible promoter RD29A (Kasuga et al (1999) Nature Biotechnol 17: 287-91); 2) the barley promoter, B22E; The expression of B22E is specific for the pedicle of developing corn grains ("Primary Structure of a Novel Barley Gene Differentially Expressed in Immature Aleurone Layers." Klemsdal,
S. S. et al. , Mol. Gen. Genet. 228 (1/2): 9-16 (1991)); and 3) corn promoter, Zag2 ("Identification and molecular characterization of ZAGl, the maize homolog of the Arabidopsis floral homeotic gene AGAMOUS", Schmidt, RJ et al., Plant Cell 5 (7): 729-737 (1993)) . "Structural characterization, chromosomal localization and phylogenetic evaluation of two pairs of AGAMOUS-like ADS-box genes from maize", Theissen et al. , Gene 156 (2): 155-166 (1995); Registration number of the Genbank of CNIB X80206)). Zag2 transcripts can be detected 5 'days before pollination up to 7 to 8 days after pollination (DDP) and direct expression
in the carpel of developing female inflorescences and Ciml that is specific to the nucleus of developing corn grains. The Ciml transcript is detected 4 to 5 days before pollination up to 6 to 8 DDP. Other useful promoters include any promoter that can be derived from a gene whose expression is maternally associated with developing female buds.
The preferred additional promoters for regulating the expression of the nucleotide sequences of the present invention in plants are the specific vascular element promoters or the stem preferred ones. Such preferred stem promoters include the alfalfa S2A promoter (GenBank registration number EF030816, Abrahams et al., Plant Mol. Biol. 27: 513-528 (1995)) and the S2B promoter (GenBank registration number EF030817). and the like, incorporated herein by reference.
The promoters can be derived in their entirety from a native gene or they can be composed of different elements derived from different promoters1 found in nature, or even comprise synthetic segments of DNA. Those skilled in the art understand that different promoters can direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. It is also recognized that since in most cases the precise boundaries of the regulatory sequences have not been fully defined, the DNA fragments of some variation may have an identical promoter activity. Promoters that cause a gene to be expressed in most types of cells, are most commonly referred to as "constitutive promoters". New promoters of various useful types in plant cells are constantly being discovered; several examples can be found in the compilation by Okamuro, J. K., and Goldberg, R. B., Biochemistry of Plants 15: 1-82 (1989). (Add this to the description of other constituent promoters.)
Preferred promoters may include: RIP2, mLlP15,
ZmCORl, Rabl7, CaMV 35S, RD29A, B22E, Zag2, SAM synthetase, ubiquitin (sec. With ident.ID: 59), CaMV 19S, nos, Adh, sucrose synthase, R-allele, promoter of the cells of the root, the vascular tissue-specific promoters S2A (Genbank registration number EF030816; sec. with ident.ID: 60) and S2B (Genbank registration number EF030817) and the constitutive promoter GOS2 (sec. ident .: 58) of sweet corn. Other preferred promoters include preferred root promoters, such as the maize AS2 promoter (SEQ ID NO: 57), the Corn Cyclo promoter (U.S. Patent No. 2006/0156439 published on 13 July 2006), the corn ROOTMET2 promoter (patent number WO05063998 published on July 14, 2005), the CR1BIO promoter (patent number WO06055487 published May 26, 2006), CR AQ81 (patent number WO05035770). published on April 21, 2005) and corn promoter ZRP2.47 (CNIB registration number: U38790, gi: 1063664).
A "substantial portion" of a nucleotide sequence comprises a sufficient nucleotide sequence to allow putative identification of the promoter comprising the nucleotide sequence. The nucleotide sequences can be evaluated either manually, by a person skilled in the art, or with the use of automated tools for the
i
comparison and identification of sequences employing algorithms, such as BLAST (tool for basic local alignment search; Altschul et al., (1993) J. Mol. Biol. 215: 403-410). Generally, a sequence of thirty or more contiguous nucleotides is required to presumably identify a nucleic acid promoter sequence as the homologue of a known promoter. The skilled artisan, with the benefit of the sequences as reported herein, may now use all or a substantial portion of the sequences described for known purposes to those skilled in the art. Therefore, the invention herein comprises the complete sequences as reported in the attached sequence listing, as well as the substantial portions of those sequences, as described above.
The recombinant DNA constructs (and suppressor DNA constructs) of the present invention may also include other regulatory sequences, including, but not limited to, leader translation sequences, introns, and polyadenylation recognition sequences. In another preferred embodiment of the present invention, a recombinant DNA construct of the present invention also comprises an enhancer or silencer.
A sequence of introns can be added to the 5 'untranslated region or the coding sequence of the partial coding sequence to increase the amount of mature message that accumulates in the cytosol. The inclusion of a divisible intron in the transcription unit in the expression constructs, both of plants and animals, has been shown to increase the genetic expression at both mRNA and protein levels up to 1000 times. Buchman and Berg, Mol. Cell Biol. 8: 4395-4405 (1988); Callis et al., Genes Dev. 1: 1183-1200 (1987). The enhancement of gene expression introns is typically greater when placed near the 5 'end of the transcription unit. The use of Adhl-S corn introns, intron 1, 2 and 6, the Bronze-1 intron is known in the art. See, in general, The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, New York (1994).
If expression of the polypeptide is desired, it is generally preferred to include a polyadenylation region at the 3 'end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, a large variety of plant genes or T-DNA. The 3 'end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes or, alternatively, from another plant gene or, less preferably, from any other eukaryotic gene.
A leader translation sequence is a DNA sequence located between the promoter sequence of a gene and the coding sequence. The translation leader sequence is present in the processed mRNA completely upstream of the initial translation sequence. The translation leader sequence can affect the processing of the primary transcript to mRNA, the stability of the mRNA or the efficiency of the translation. Examples of leading translation sequences have been described (Turner, R. and Foster, G. D. Molecular Biotechnology 3: 225 (1995)).
In another preferred embodiment of the present invention, a recombinant DNA construct of the present invention also comprises an enhancer. or silencer.
Any plant can be selected for the identification of regulatory sequences and genes for use in the creation of recombinant DNA constructs and DNA suppressor constructs of the present! invention. Examples of suitable target plants for the isolation of genes and regulatory sequences include, but are not limited to, alfalfa, apple, apricot, Arabidopsis, artichoke, arugula, asparagus, avocado, banana, barley, beans, beets, blackberry, cranberry vaccinio, broccoli, cabbage, brussels, cabbage, cañola, cantaloupe, carrot , cassava, castor seed, cauliflower, celery, cherry, chicory, coriander, citrus, clementine, clover, coconut, coffee, corn, cotton, cranberry, cucumber, Douglas fir, eggplant, endive, escarole, eucalyptus, fennel, fig trees, garlic, pumpkin, grape, grapefruit, green pulp melon, jicama, kiwi, lettuce, leek, lemon, lime, taeda pine, flaxseed, mango, melon, mushrooms, nectarine, walnut, oats, oil palm, rapeseed oil, okra , olive, onion, orange, an ornamental plant, palm, papaya, parsley, parsnip, pea, peach, peanut, pear, chili, persimmon, pine, pineapple, banana, plum, red pomegranate, poplar, potato, squash, quince, Monterey pine, chicory, radish, rapeseed, raspberry, rice, rye, sorghum, marsh pine, soybean, spinach, zucchini, strawberry, sugar beet, sugar cane, sunflower, sweet potato, amber tree, tangerine, tea, tobacco, tomato, triticum, turf, turnip, vine, watermelon, wheat, yams and zucchini. Particularly preferred plants for the identification of regulatory sequences are Arabidopsis, corn, wheat, soybeans and cotton.
Preferred compositions
A preferred composition of the present invention is a plant that comprises in its genome any of the recombinant DNA constructs (including any of the DNA suppressor constructs) of the present invention (such as the preferred constructs mentioned above). Preferred compositions also include any progeny of the plant and any seed obtained from the plant or its progeny, while the progeny or seed comprises within its genome the recombinant DNA construct (or suppressor DNA construct). The progeny include later generations obtained through self-pollination or crossing a plant. The progeny also includes hybrids and inbreds.
Preferably, in cultures propagated by hybrid seeds, mature transgenic plants can self-pollinate to produce a homozygous inbred plant. The inbred plant produces seeds that contain the newly introduced recombinant DNA construct (or suppressor DNA construct). These seeds can be grown to produce plants that will show alterations in the radicular (or plant) architecture, or they can be used in a breeding program to produce hybrid seeds, which can be grown to produce plants that will show alterations in the radicular architecture (or of the plant) '. Preferably, the seeds are corn.
Preferably, the plant is a monocotyledonous or dicotyledonous plant, more preferably, a corn or soybean plant, even more preferably, a corn plant, such as a hybrid corn plant or an inbred maize plant. The plant can also be sunflower, sorghum, barley, wheat, alfalfa, cotton, rice, barley or millet.
Preferably, the recombinant DNA construct is stably integrated into the genome of the plant.
Particularly preferred embodiments include, but are not limited to, the following preferred embodiments:
1. A plant (preferably, a corn or soy bean plant) comprising in its genome a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence, wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%,
56%, 57%, 58%, 59%, 60%, 56, 62%, 63%, 64%, 65 66%,
67 68%, 69 70%, 71%, 72, 73%, 74 75%, 76%, 77%,
78%, 79%, 80%, 81 82%, 83 84%, 85%, 86%, 87%, 88%,
89%, 90%, 91%, 92%, 93%, 94 95%, 96%, 97%, 98, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to the sec with no. Ident .: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42 and where the plant shows alterations in the radicular architecture when compared with a plant control that does not comprise the recombinant DNA construct. Preferably, the plant also shows some alteration of at least one agronomic characteristic when compared to the control plant.
2. A plant (preferably, a corn or soybean plant) that comprises in its genome:
a recombinant DNA construct comprising: (a) a polynucleotide operably linked to at least one regulatory element, wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% sequence identity, based on the method of Clustal V alignment, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42, or
(b) a suppressor DNA construct comprising at least one regulatory element that is operationally linked:
(i) all or part of: (A) a nucleic acid sequence encoding a polypeptide with an amino acid sequence of at least 50% sequence identity, based on Clustal V alignment method, when compared to sec. with no. of ident: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42 or (B) a complete complement of the nucleic acid sequence of (b) (i) (A); or
(ii) a region derived from all or part of a sequencer or from, a non-coding strand of a target gene of interest; the region with a nucleic acid sequence of at least 50% sequence identity, based on the Clustal V alignment method, when compared to all or part of a sequencer or non-coding strand from which the region and wherein the target gene of interest encodes a REP2 or polypeptide similar to a REP2 and wherein the plant shows some alteration of at least one agronomic characteristic as compared to a control plant that does not comprise the recombinant DNA construct.
3. A plant (preferably, a corn or soy bean plant) comprising in its genome a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence, wherein the polynucleotide encodes a REP2 or protein similar to a REP2 and where the plant shows alteration in the radicular architecture compared to a control plant that does not comprise the recombinant DNA construct. Preferably, the plant also exhibits some alteration of at least one agronomic characteristic.
Preferably, the REP2 protein is derived from Arabidopsis thaliana, Zea mays, Glycine max, Glycine tabacin, Glycine soya or Glycine tomentella.
4. A plant (preferably, a corn or soy bean plant) comprising in its genome a DNA suppressor construct comprising at least one regulatory element operably linked to a region derived from all or part of a sequencer or chain non-coding for a target gene of interest; the region with a nucleic acid sequence of at least 50%, 51%, 52%, 53%, 54 55%, 56%, 57%,
58%, 59%, 60%, 56%, 62%, 63%, 64%, 65, 66%, 67%, 68%,
69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%,
80%, 81%, 82%, 83, 84%, 85%, 86%, 87%, 88%, 89%, 90%,
91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to the totality or part of a sequencer or of a non-coding chain from which the region is derived and in which the target gene of interest encodes a REP2 or protein similar to a REP2 and where the plant shows some alteration of at least one agronomic characteristic in comparison with a control plant that does not comprise the recombinant DNA construct. 1
5. A plant (preferably, a corn or soybean plant) comprising in its genome a suppressor DNA construct comprising at least one regulatory element operably linked
I
all or a part of (a) a nucleic acid sequence encoding a polypeptide with an amino acid sequence of at least 50 o,
¾ / 51 or, or,
¾ / 52%, 53 ¾ / 54%, 55%, 56%, 57 ¾, 58%, 59%,
60%, 56%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70,
71%, 72%, 73%, 74, 75 o.
o 76%, 77%, 78%, 79%, 80%, 81%,
82%, 83 O.
%, 84"or 1 85 0,
• or 1 86%, 87 or,
° 1 88%, 89%, 90%, 91%, 92 O
¾ /
93%, 94%, 95%, 96 0.
"O / 97 98 o,
"° 1 99" S or 100% sequence identity, based on the Clustal V alignment method, when compared to sec. with no. of ident: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42, or (b) a total complement of the nucleic acid sequence of (a) ) and wherein the plant shows some alteration of at least one agronomic characteristic as compared to a control plant that does not comprise the recombinant DNA construct.
6. Any progeny of the plants mentioned above in the preferred embodiments 1-5, any seed of the plants mentioned above in the preferred embodiments 1-5, any seed of the progeny of the plants mentioned above in the preferred embodiments 1-5 and the cells from any of the plants mentioned above in the preferred embodiments 1-5, as well as the progeny thereof.
In any of the preferred embodiments 1-6 mentioned above or in any other embodiment of the present invention, the recombinant DNA construct (or suppressor DNA construct) preferably comprises at least one functional promoter in a plant as a regulatory sequence. preferred
In any of the preferred embodiments 1-6 mentioned above or in any other embodiment of the present invention, the alteration of at least one agronomic characteristic is an increase or decrease, preferably an increase.
In any of the preferred embodiments 1-6 mentioned above or in any other embodiment of the present invention, at least the only agronomic characteristic is preferably selected from the group consisting of verdure, yield, growth index, biomass, fresh weight in maturation, dry weight in ripening, fruit production, seed production, total nitrogen content in the plant, nitrogen content in the fruits, nitrogen content in the seeds, nitrogen content in a vegetative tissue, total content of free amino acids in the plant, content of free amino acids in the fruits, content of free amino acids in the seeds, content of free amino acids in a vegetative tissue, total content of proteins in the plant, content of proteins in the fruits, content of proteins in the seeds, content of proteins in a vegetative tissue, tolerance to drought, uptake of nitr ogen, root mass, root location, stem location, plant height, spike length and harvest index. The yield, greenness, biomass and location of the root are preferred agronomic characteristics particularly for the alteration (preferably, an increase).
In any of the preferred embodiments 1-6 mentioned above or any other embodiment of the present invention, the plant preferably exhibits the alteration of at least one agronomic characteristic independently of environmental conditions, eg, availability of water and nutrients, compared to a control plant.
A person skilled in the art becomes familiar with the protocols for determining the alteration in the radicular architecture of plants. For example, transgenic corn plants can be analyzed to identify changes in the radicular architecture in the seedling stage, at the time of flowering or of maturity. The alterations in the radicular architecture can be determined by counting the nodal roots of the 3 or 4 superior nodules of the plants grown in greenhouses or the width of the root band. "Radicular band" refers to the width of the root structure in the bottom of a pot at the stage of maturity of the plant. Other indicators of alterations in the root architecture include, but are not limited to, the number of lateral roots, average diameter of the nodal roots, average diameter of the lateral roots, number and length of the villi of the root. The degree of branching of the lateral roots (for example, the number of lateral roots, the length of the lateral roots) can be determined by subsampling a complete root system, obtaining images with a flatbed scanner or camera digital and analysis with the WinRHIZO ™ program (Regent Instruments Inc.).
The data taken from the root phenotype are subject to statistical analysis, usually a t test to compare the transgenic roots with; the roots of non-transgenic sister plants. The unidirectional A OVA test can also be used in cases where multiple events and / or constructs are involved in the analysis.
The examples below describe some representative protocols and techniques for detecting alterations in the root architecture.
It is also possible to evaluate the alterations in the radicular architecture by means of the capacity of the plant to increase the production in the field tests in comparison with a control or reference plant, under the same conditions.
It is also possible to evaluate the alterations in the radicular architecture by means of the capacity of the plant to maintain a substantial production (preferably, at least 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82% , 83, 84%,
85%, 86 ° r 87 88, 89%, 90%, 91%, 92%, 93%, 94%, 95%,
96%, 97%, 98%, 99% or 100% of production) i in field tests under stress conditions (for example, overabundance or nutrient limitation, overabundance or limitation of water, presence of disease), 'when it is compared with the production of a control or reference plant under non-stress conditions.
Alterations in the root architecture can also be identified by determining the resistance to the root location of the transgenic plants compared to reference or control plants.
One skilled in the art would readily recognize a suitable control or reference plant for use in evaluating or determining an agronomic characteristic or phenotype of a transgenic plant in any embodiment of the present invention where a control or reference plant is used (e.g. the compositions or methods as described herein). For example, by way of non-limiting illustrations:
1. The progeny of a transformed plant that is hemiguous with respect to a recombinant DNA construct (or suppressor DNA construct), such that the progeny is secreted into plants whether or not they comprise the recombinant DNA construct (or Suppressor DNA): the progeny comprising the recombinant DNA construct (or suppressor DNA construct) will typically be determined in relation to progeny that does not comprise the recombinant DNA construct (or suppressor DNA construct) (ie, the progeny that do not comprise the recombinant DNA construct (or DNA suppressor construct) is the control or reference plant).
2. The introgression of a recombinant DNA construct
(or suppressor DNA construct) in an inbred line, such as corn, or in a variety;, such as soybean: the introgress line is typically measured in relation to the progenitor or variety inbred line (i.e. the progenitor or variety inbred line is the control or reference plant).
3. Two hybrid lines, where the first hybrid line is produced from two inbred progenitor lines and the second hybrid line is produced from the same two inbred progenitor lines, except that one of the inbred progenitor lines contains a recombinant DNA construct (or suppressor DNA construct): the second hybrid line will typically be determined in relation to the first hybrid line (i.e., the progenitor or variety inbred line is the control or reference plant).
4. A plant comprising a recombinant DNA construct (or DNA suppressor construct): the plant can be evaluated or determined in relation to a control plant that does not comprise the recombinant DNA construct (or suppressor DNA construct), but on the other hand, with a genetic background comparable to the plant (for example, sharing at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% identity). sequences of the nuclear genetic material compared to the plant comprising the recombinant DNA construct (or DNA suppressor construct) There are several laboratory techniques available for the analysis, comparison and characterization of the genetic background of the plant; isoenzyme electrophoresis, restriction fragment length polymorphism (RFLP), randomly amplified polymorphic DNA (RAPD), p-chain reaction randomly initiated olimerase (AP-PCR), DNA fingerprint amplification (DAF), amplified regions characterized by sequences (SCAR), polymorphism of length of amplified fragments (AFLP®) and repetitions of simple sequences (SSR) also called microsatellites.
Furthermore, one skilled in the art would readily recognize that a suitable control or reference plant that is used in evaluating or determining an agronomic trait or phenotype of a transgenic plant would not include a plant that has been previously selected, by mutagenesis or transformation, for agronomic characteristic or desired phenotype.
Preferred methods
Preferred methods include, but are not limited to, methods for altering the root architecture in a plant, methods for evaluating the alteration in the radicular architecture in a plant, methods for altering an agronomic characteristic in a plant, methods for determine the alteration of an agronomic characteristic in a plant and the methods to produce seed. Preferably, the plant is a monocotyledonous or dicotyledonous plant, more preferably, a corn or soybean plant, even more preferably, a corn plant. The plant can also be sunflower, sorghum, barley, wheat, alfalfa, cotton, rice, barley or millet. The seed is preferably a corn or soybean seed, more preferably a corn seed and, even more preferably, a hybrid seed of maize or corn inbred seed.
Particularly preferred methods include, but are not limited to, the following:
A method to alter the radicular architecture of a plant; the method comprises: (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence (preferably, a functional promoter in a plant), wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50.51%, 52%,
53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 56%, 62%, 63%
64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74
75%, 76%, 77 78 79, 80%, 81%, 82%, 83%, 84%, 85%
86%, 87%, 88 89%, 90, 91%, 92%, 93%, 94%, 95%, 96%
97%, 98%, 99% OR 100% sequence identity, based on the Clustal V alignment method, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42; and (b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the recombinant DNA construct and shows alteration in the radicular architecture as compared to a control plant which does not comprise the recombinant DNA construct. The method may also comprise (c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the recombinant DNA construct and shows alteration in the radicular architecture in comparison with a control plant that does not comprise the construct. of recombinant DNA.
A method to alter the radicular architecture in a plant; the method comprises: (a) introducing into a regenerable plant cell a suppressor DNA construct comprising at least one regulatory sequence (preferably, a functional promoter in a plant) that is operationally linked:
(i) in whole or in part to: (A) a nucleic acid sequence encoding a polypeptide with an amino acid sequence of at least 50%, 51%, 52%, 53.54%, 55%,
56%, 57 ° r 58%, 59%, 60%, 56%, 62%, 63%, 64 65%, 66
67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77
78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88
89%, 90 91%, 92%, 93%, 94%, 95%, 96%, 97 98%, 9: or 100% sequence identity, based on Clustal V alignment method, when compared to the sec . with no. Ident.: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39,
41 or 42o (B) a total complement of the nucleic acid sequence of (a) (i) (A); or
(ii) a region derived from all or part of a sequencer or non-coding strand of a target gene of interest; the region with a nucleic acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 56%, 62% , 63%, 64%, 65%, 66%, 67%, 68%, 69%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89, 90% , 91%, 92%, 93%, 94%, 95%, 96% (97%, 98%, 99% or 100% sequence identity, based on Clustal V alignment method, when compared to the totality or part of a sequencer or non-coding chain from which the region is derived and in which the target gene of interest encodes a REP2 or polypeptide similar to a REP2;
(b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the recombinant DNA construct and shows alteration in the radicular architecture in comparison with a control plant that does not understand the suppressor DNA construct. The method may also comprise (c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the recombinant DNA construct and shows alteration in the radicular architecture as compared to a control plant that does not comprise the construct. of DNA suppressor.
A method to evaluate alterations in the radicular architecture in a plant; The method comprises (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence (preferably, a functional promoter in a plant), wherein the polynucleotide encodes a polypeptide with a amino acid sequence of at least 50%, 51 52%, 53 54 55 56%, 57%, 58%, 59 60%, 56%,
62 63 64 65 66 67%, 68%, 69%, 70 71%, 72%,
73%, 74 75 76%, 77 78%, 79%, 80%, 81 82%, 83%,
84 85 86 87 88 89%, 90%, 91%, 92 93%, 94%,
95 96, 97%, 98 99 OR 100% sequence identity, based on Clustal V alignment method, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42 (b) regenerate a transgenic plant from the regenerable plant cell after the stage (a) ), wherein the transgenic plant comprises in its genome the recombinant DNA construct; and (c) evaluating the radicular architecture of the transgenic plant as compared to a control plant that does not comprise the recombinant DNA construct. The method may also comprise (d) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the recombinant DNA construct; and (e) evaluating the radicular architecture of the progeny plant as compared to a control plant that does not comprise the recombinant DNA construct.
A method to evaluate alterations in the radicular architecture in a plant; the method comprises (a) introducing into a regenerable plant cell a suppressor DNA construct comprising at least one regulatory sequence (preferably, a functional promoter in a plant) that is operationally linked:
(i) in whole or in part to: (A) a nucleic acid sequence encoding a polypeptide with an amino acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%,
56%, 57%, 58%, 59%, 60%, 56 62%, 63 64%, 65%, 66%,
67%, 68 69 ° ^ 70%, 71%, 72%, 73%, 74, 75, 76%, 77%,
78 79%, 80 81%, 82%, 83 84 85%, 86%, 87%, 88%,
89%, 90%, 91%, 92%, 93%, 94 ¾. 95%, 96%, 97 r 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to sec. with no. of ident: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42, or (B) a total complement of the nucleic acid sequence of (a ) (i) (A), or (ii) a region derived from all or part of a sequencer or non-coding strand of a target gene of interest; the region with a nucleic acid sequence of at least 50%, 51 ¾, 52%, 53 54 ¾ / 55%, 56%,
57%, 58%, 59%, 60%, 56%, 62%, 63%, 64%, 65%, 66%, 67%,
68%, 69%, 70%, 71%, 72%, 73%, 74 ¾ / 75%, 76%, 77, 78%,
79%, 80%, 81%, 82%, 83%, 84%, 85%, 86, 87 88, 89%,
90%, 91%, 92%, 93%, 94%, 95% 96%, 97%. 98 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to all or part of a sequencer or non-coding chain from which the region is derived and in which the target gene of interest encodes a REP2 or polypeptide similar to a REP2; Y
(b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the suppressor DNA construct; and (c) evaluating the transgenic plant to identify alterations in the radicular architecture as compared to a control plant that does not comprise the suppressor DNA construct. The method may also comprise (d) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the suppressor DNA construct; and (e) evaluating the progeny plant to identify alterations in the radicular architecture compared to a control plant that does not comprise the suppressor DNA construct.
A method for evaluating alterations in the radicular architecture in a plant method comprises (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operatively linked to at least one regulatory sequence (preferably, a functional promoter in a plant) , . wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50%,
51, 52%, 53%, 54%, 55"o / 56%, 57%, 58%, 59%, 60%, 56% 62%, 63 64 65%, 66%, 67%, 68%, 69 %, 70%, 71%, 72%
73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%
84%, 85 86%, 87%, 88%, 89%, 90%, 91%, 92 93% * 94%
95%, 96 97%, 98%, 99 * 5 OR 100% sequence identity based on the Clustal V alignment method, when compared to sec. connúm. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42 (b) regenerating a transgenic plant from the regenerable plant cell after the stage (a) ), wherein the transgenic plant comprises in its genome the recombinant DNA construct; (c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the recombinant DNA construct; and (d) evaluating the progeny plant to identify alterations in the radicular architecture as compared to a control plant that does not comprise the recombinant DNA construct.
A method to evaluate the radicular architecture in a plant; The method includes:
(a) introducing into a regenerable plant cell a suppressor DNA construct comprising at least one regulatory element that is operationally linked: (i) in whole or in part to: (A) a nucleic acid sequence encoding a polypeptide with a sequence of amino acids of at least 50%, 51%, 52%
53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 56%, 62, 63%
64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72 73%, 74%
75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85% 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%
97%, 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42, or (B) a total complement of the nucleic acid sequence of (a) (i) ) (TO); or (ii) a region derived from all or part of a sequencer or a non-coding strand of a target gene of interest; the region with a nucleic acid sequence of at least 50%, 51%, 52%,
53%, 54%, 55%, 56%, 57%, 58%, 59 60%, 56%, 62%, 63%
64%, 65%, 66 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%
75 76%, 77 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%
86%, 87%, 88%, 89%, 90%, 91%, 92 93%, 94%, 95%, 96%
97 98%, 99% OR 100% sequence identity, based on the Clustal V alignment method, when compared to all or part of a sequencer or non-coding chain from which the region is derived and in which the target gene of interest encodes a REP2 or polypeptide similar to a REP2; (b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the suppressor DNA construct;
(c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the suppressor DNA construct; and (d) evaluating the radicular architecture of the progeny plant as compared to a control plant that does not comprise the suppressor DNA construct.
A method to determine the alterations of an agronomic characteristic in a plant; The method comprises (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence (preferably, a functional promoter in a plant), wherein the polynucleotide encodes a polypeptide with a amino acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 56%, 62%, 63%, 64 %, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97% , 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42 (b) regenerating a transgenic plant from the regenerable plant cell after the stage (a) ), wherein the transgenic plant comprises in its genome the recombinant DNA construct; and (c) determining whether the transgenic plant shows any alteration of at least one agronomic characteristic as compared to a control plant that does not comprise the recombinant DNA construct. The method may also comprise (d) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the recombinant DNA construct; and (e) determining whether the progeny plant shows any alteration of at least one agronomic characteristic as compared to a control plant that does not comprise the recombinant DNA construct.
A method to determine the alterations of an agronomic characteristic in a plant; the method comprises (a) introducing into a regenerable plant cell a suppressor DNA construct comprising at least one regulatory sequence (preferably, a functional promoter in a plant) that is fully or partially operationally linked to (i) an acid sequence nucleic acid encoding a polypeptide with an amino acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%,
56%, 57%, 58%, 59%, 60%, 56%, 62%, 63%, 64"o / 65%, 66%,
67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%,
78%, '79%, 80%, 81%, 82% 83%, 84%, 85%, 86%, 87%, 88%,
89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97 98%, 99% or 100 O, of sequence identity, based on the Clustal V alignment method, when compare with sec. with no. of ident: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42o (ii) a total complement of the nucleic acid sequence of (i); (b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the suppressor DNA construct; and (c) determining whether the transgenic plant shows an alteration in at least one agronomic characteristic as compared to a control plant that does not comprise the suppressor DNA construct. The method may also comprise (d) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the suppressor DNA construct; and (e) determining whether the progeny plant shows an alteration in at least one agronomic characteristic as compared to a control plant that does not comprise the suppressor DNA construct.
A method to determine the alterations of an agronomic characteristic in a plant; The method comprises (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence (preferably, a functional promoter in a plant), wherein the polynucleotide encodes a polypeptide with a amino acid sequence of at least 50%, 51%, 52%, 53%, 54% 55%, 56%, 57%, 58%,
59%, 60%, 56%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%,
70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%,
81 s t 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%,
92%, 93%, 94% 95%, '96%, 97%, 98%, 99 or 100% sequence identity, based on the Clustal V alignment method, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42 (b) regenerate a transgenic plant from the regenerable plant cell after the stage ( a), wherein the transgenic plant comprises in its genome the recombinant DNA construct; (c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the recombinant DNA construct; and (d) determining whether the progeny plant shows any alteration of at least one agronomic characteristic as compared to a control plant that does not comprise the
recombinant DNA construct. The method for determining alterations of an agronomic characteristic in a plant may also comprise determining whether the transgenic plant shows any alteration of at least one agronomic characteristic when comparing, under various environmental conditions, with a control plant that does not comprise the Recombinant DNA
A method to determine the alterations of an agronomic characteristic in a plant; the method comprises (a) introducing into a regenerable plant cell a suppressor DNA construct comprising at least one regulatory sequence (preferably, a functional promoter in a plant) that is fully or partially operationally linked to (i) an acid sequence nucleic acid encoding a polypeptide with an amino acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%,
56%, 57%, 58%, 59%, 60%, 56%, 62%, 63%, 64%, 65%, 66%,
67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%,
78%, 79%, 80% 81% / 82% / 83 84%, 85%, 86%, 87%, 88%,
89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when it is compared to sec. with no. of ident: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42o (ii) a total complement of the nucleic acid sequence of (i);
(b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the suppressor DNA construct; (c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the suppressor DNA construct; and (d) determining whether the progeny plant shows an alteration in at least one agronomic characteristic as compared to a control plant that does not comprise the recombinant DNA construct.
A method to determine the alterations of an agronomic characteristic in a plant; The method comprises: (a) introducing into a regenerable plant cell a suppressor DNA construct comprising at least one regulatory element that is operationally linked to a region derived in whole or in part from a sequencer or from a non-coding strand of a target gene of interest, the region with a nucleic acid sequence of at least 50%, 51, 52%, 53% 54% 55%, 56%, 57%, 58
59%, 60%, 56%, 62%, 63%, 64%, 65%, 66%, 67 68%, 69
70%, 71 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80
81%, 82%, 83%, 84%, 85%, 86, 87%, 88%, 89%, 90%, 91
92%, 93%, 94% 95%, 96%, 97%, 98%, 99% OR 100% sequence identity, based on the Clustal V alignment method, when compared to all or part of a sequencer or of a non-coding chain from which the region is derived and in which the target gene of interest encodes a REP2 or polypeptide similar to a REP2; (b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the suppressor DNA construct; and (c) determining whether the transgenic plant shows any alteration of at least one agronomic characteristic when compared to a control plant that does not comprise the suppressor DNA construct. The method may also comprise: (d) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome 1 suppressor DNA construct; and (e) determining whether the progeny plant shows any alteration of at least one agronomic characteristic as compared to a control plant that does not comprise the suppressor DNA construct.
A method to determine the alterations of an agronomic characteristic in a plant; the method comprises: (a) introducing into a regenerable plant cell a suppressor DNA construct comprising at least one regulatory element operably linked to a region derived from all or part of a sequencer or a non-coding strand of a target gene of interest, the region with a nucleic acid sequence of at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 56% , 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78 %, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity, based on the Clustal V alignment method, when compared to all or part of a sequencer or non-coding chain from where the region is derived and in which the target gene of interest encodes a REP2 or polypeptide similar to a REP2; (b) regenerating a transgenic plant from the regenerable plant cell after step (a), wherein the transgenic plant comprises in its genome the suppressor DNA construct; (c) obtaining a progeny plant derived from the transgenic plant, wherein the progeny plant comprises in its genome the suppressor DNA construct; and (d) determining whether the progeny plant shows any alteration of at least one agronomic characteristic as compared to a control plant that does not comprise the suppressor DNA construct.
A method for producing seed (preferably, seed that can be sold as an offer of products with alteration in the radicular architecture) comprising any of the above preferred methods and also comprising obtaining seeds from the progeny plant, wherein the seeds comprise in its genome is the recombinant DNA construct (or suppressor DNA construct).
In any of the preferred methods mentioned above or any other mode of the methods of the present invention, the step to determine the alterations of an agronomic characteristic in a transgenic plant, if applicable, should preferably comprise determining whether the transgenic plant shows any alteration of at least one agronomic characteristic when comparing, under various environmental conditions, with a control plant that does not comprise the recombinant DNA construct.
In any of the preferred methods mentioned above or any other mode of the methods of the present invention, the step to determine the alterations of an agronomic characteristic in a progeny plant, if applicable, should preferably comprise determining whether the progeny plant shows any alteration of at least one agronomic characteristic when comparing, under various environmental conditions, with a control plant that does not comprise the recombinant DNA construct.
In any of the above preferred methods or any other embodiment of the methods of the present invention, in the introduction step the regenerable plant cell preferably comprises a cell, callose
(preferably, embryogenic), a gamética cell, a meristematic cell or a cell of an immature embryo. The regenerable plant cells are preferably from an inbred maize plant.
In any of the foregoing preferred methods or any other mode of the methods of the present invention, the regenerative step preferably comprises: (i) culturing the transformed plant cells in a medium comprising an embryogenic promoter hormone until a callus structure is observed; (ii) transferring the transformed plant cells of step (i) to a first medium including a tissue structure promoting hormone; and (iii) subculturing the transformed plant cells after step (ii) in a second medium, to allow elongation of the shoots, root development or both.
In any of the foregoing preferred methods or any other mode of the methods of the present invention, there are alternatives for introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operatively linked to at least one regulatory sequence. For example, a regulatory sequence (such as one or more enhancers, preferably, as part of a transposable element) can be introduced into a regenerable plant cell and then screened for an event in which the regulatory sequence is operationally linked to a endogenous gene encoding a polypeptide of the instant invention.
The introduction of recombinant DNA constructs of the present invention into plants can be carried out by any of the suitable techniques, including, but not limited to, direct DNA uptake, chemical treatment, electroporation, microinjection, cell fusion, infection, vector-mediated DNA transfer, bombardment or transformation mediated with Agrrojacterium.
In any of the above preferred methods or any other modality of the methods of the present invention, at least the only agronomic characteristic is preferably selected from the group consisting of verdure, yield, growth index, biomass, fresh weight at maturity , dry weight in ripening, fruit production, seed production, total nitrogen content in the plant, nitrogen content in the fruits, nitrogen content in the seeds, nitrogen content in a vegetative tissue, total content of free amino acids in the plant, content of free amino acids in the fruits, content of free amino acids in the seeds, content of free amino acids in a vegetative tissue, total content of proteins in the plant, content of proteins in the fruits, content of proteins in the seeds , content of proteins in a vegetative tissue, tolerance to drought, nitrogen uptake, ma sa from the root, location of the root, location of the stem, height of the plant, length of the ears and harvest index. The yield, greenness, biomass and location of the root are preferred agronomic characteristics .particularly for the alteration (preferably, an increase).
In any of the foregoing preferred methods or any other mode of the methods of the present invention, the plant preferably exhibits the alteration of at least one agronomic characteristic independently of environmental conditions when compared to a control one.
The introduction of recombinant DNA constructs of the present invention into plants can be performed by any of the suitable techniques, including, but not limited to, direct DNA uptake, chemical treatment, electroporation, microinjection, cell fusion, infection, vector-mediated DNA transfer, bombardment or Agrobacterium-mediated transformation.
Preferred techniques for the transformation of maize plant cells and soy bean plant cells are described in the examples below.
Other preferred methods for transforming dicots, mainly with the use of Agrobacterium tumefaciens and obtaining transgenic plants include markets published on cotton (U.S. Patent No. 5,004,863, U.S. Patent No. 5,159,135, U.S. 5,518, 908); soybeans (U.S. Patent No. 5,569,834, U.S. Patent No. 5,416,011, McCabeet. al., Bio / Technology 6: 923 (1988), Christou et al., Plant Physiol. 87: 671 674 ( 1988)); mustard (U.S. Patent No. 5,463,174); peanut (Cheng et al., Plant Cell Rep. 15: 653-657 (1996), McKently et al., Plant Cell Rep. 14: 699-703 (1995)); papaya; and peas (Grant et al., Plant Cell Rep. 15: 254-258, (1995)).
The transformation of monocots with the use of electroporation, bombardment of particles and Agrobacterium has also been reported and preferred methods are included, for example, transformation and plant regeneration as obtained in asparagus (Bytebier et al., Proc. Nati. Acad Sci. United States 84: 5354, (1987)); barley (Wan and Lemaux, Plant Physiol., 104: 37 (1994)); sweet corn (Rhodes et al., Science 240: 204 (1988), Gordon-Kamm et al., Plant Cell 2: 603 618 (1990), Fromm et al., Bio / Technology 8: 833 (1990), Koziel et al. al., Bio / Technology 11: 194, (1993), Armstrong et al., Crop Science 35: 550-557 (1995)); oats (Somers et al., Bio / Technology 10: 1589 (1992)); ball grass (Horn et al., Plant Cell Rep. 7: 469 (1988)); rice (Toriyama et al., Theor. Appl. Genet., 205: 34, (1986), Part et al., Plant Mol. Biol. 32: 1135-1148, (1996), Abedinia et al., Aust. Physiol., 24: 133, 141 (1997), Zhang and Wu, Theor.Appl. Genet, 76: 835 (1988), Zhang et al., Plant Cell Rep. 7: 379, (1988), Battraw and Hall, Plant Sci. 86: 191202 (1992), Christou et al., Bio / Technology 9: 957 (1991)), rye (De la Pena et al., Nature 325: 274 (1987)), sugar cane (Bower and Birch, Plant J ".2: 409 (1992)), high pointer (Wang et al., Bio / Technology 10: 691 (1992)) and wheat (Vasil et al., Bio / Technology 10: 667 (1992); United States No. 5,631,152).
There are several methods to regenerate plants from plant tissue. The specific regeneration method will depend on the initial plant tissue and the plant species
individuals who are going to regenerate.
The regeneration, development and cultivation of plants from single plant protoplast transformants or from several transformed explants are well known in the art (Weissbach and Weissbach, in: Methods for Plant Molecular Biology, (Eds.), Academic Press, Inc. San Diego, CA, (1988)). Typically, this regeneration and growth process includes the steps of selecting transformed cells and culturing those individualized cells through the usual stages of embryonic development or through the seedling root stage. Embryos and transgenic seeds regenerate similarly. Then, the resulting transgenic rooted shoots are planted in an appropriate plant culture medium, such as the soil.
The development or regeneration of plants containing the foreign, exogenous nucleic acid fragment encoding a protein of interest is well known in the art. Preferably, the regenerated plants self-pollinate to provide homozygous transgenic plants. Otherwise, the pollen obtained from the regenerated plants is crossed with that of plants grown from seeds of agronomically important lines. Conversely, pollen from the plants of these important lines is used to pollinate regenerated plants. A transgenic plant of the present invention that contains a desired polypeptide is cultured by methods well known to a person skilled in the art. EXAMPLES
The present invention is illustrated in more detail in the following examples, in which the parts and percentages are by weight and the degrees are in degrees Celsius, unless otherwise indicated. It should be understood that while these examples indicate the preferred embodiments of the invention, they are provided by way of example only. From the above description and from these examples, a person skilled in the art will be able to determine the essential characteristics of this invention and, without departing from the spirit or scope thereof, may introduce various changes and modifications to the invention to adapt it to the various uses and conditions. Accordingly, various modifications of the invention in addition to those shown and described herein will be apparent to those skilled in the art from the foregoing description. The modifications will also be within the scope of the appended claims.
Example 1
Creation of a population of Arabidopsis with genes with activation labeling
A binary construct based on 18.5 kb T-DNA, pHSbarENDs2 (sec. With ident.ID: 1;) containing four multimerized enhancer elements derived from the 35S promoter of the cauliflower mosaic virus, corresponding to the sequences, was created. -341 to -64, as described by Odell et al., (1985) Nature 313: 810-812. The construct also contains vector sequences (pUC9) to allow the rescue of plasmids, transposon sequences (Ds) to remobilize T-DNA and the bar gene to allow the selection of glufosinate from transgenic plants. Only the 10.8 kb segment from the right edge (BD) to the left (BI) inclusive border will be transferred to the genome of the host plant. Since the enhancer elements are close to the BD, they can induce the cis-activation of the genomic loci followed by the integration of T-DNA.
The pHSbarENDs2 construct was transformed into the C58 strain of Agrobacterium tumefaciens, which was grown in the BI at 25 ° C for OD600 -1.0. The cells were then granulated by centrifugation and resuspended in an equal volume of 5% sucrose / 0.05% Silwet L-77 (OSI Specialties, Inc). During early germination, the Col-0 ecotype of Arabidopsis thaliana grown in the soil1 was soaked with the Agrobacterium suspension. One week later, the same plants were soaked again with the same strain of Agrroj acterium in sucrose / Silwet. The plants were allowed to leave seed as they normally do. The resulting seeds were sown in soil and transgenic seedlings were selected by atomization with glufosinate (Finale®, AgrEvo, Bayer Environmental Science). T2 seeds were harvested from approximately 35,000 individual TI plants resistant to glufosinate. The T2 plants were grown and the same volumes of T3 seeds were collected from 96 separate T2 lines. This constituted 360 subpopulations.
A total of 100, 000 TI seedlings resistant to glufosinate were selected. T2 seeds from each line were kept separate.
Example 2
Sieves to identify lines with altered root architecture
Arabidopsis seedlings with activation labeling, grown under non-limiting conditions of nitrogen, were analyzed to identify alterations in the architecture of the root system when compared with control seedlings during the early development of the population described in Example 1.
From each of the 96,000 individual IT lines with activation labeling, ten T2 seeds were sterilized with chlorine gas and planted in Petri dishes with the following medium: Hoagland solution 0.5x without N, 60 mM K 03, 0.1% sucrose, 1 mM of MES and 1% of Phytagel ™. Typically, 10 plates were placed on a shelf. The plates were kept at 4 ° C for three days to stratify the seeds, and then they were held vertically for 11 days at 22 ° C with light and at 20 ° C with darkness. The period of exposure to light was 16 h; 8 h of darkness, the average light intensity was -180 mol / m2 / s. The shelves (typically, with 10 plates each) were rotated daily within each shelf. On day 14, the condition of the seedlings of the plates was evaluated, digital images of the whole plate were taken and analyzed for the root area. The plates were arbitrarily divided into 10 horizontal areas. The radicular area in each of the 10 horizontal zones on the plate was expressed as a percentage of the total area. Only the areas in zones 3 through 9 were used to determine the total root area of the line. The tool for the analysis of Rootbot images (registered trademark) was developed by ICORIA to analyze the root area. The total root area was expressed in mm2.
It was expected that the lines with enhanced root growth characteristics would be found at the upper end of the distributions of the radicular area. A sliding window approach was used to determine the variation in the root area for a given shelf assuming there could be up to two outliers on the shelf. Environmental variations in several factors that include growth medium, temperature and humidity can cause significant variations in root growth, especially between sowing dates. Therefore, the lines were grouped by planting date and shelf for data analysis. Then, shelves on a particular sowing date or group of shelves were classified by average radicular area. The radicular area distributions for sliding windows were made by combining the data from one rack, ri, with the rack data with the next lower average radicle area, (ri-i and the next larger average radicle area, ri + i Then the variation of the combined distribution was analyzed to identify the outliers in ri with the use of a Grubbs type approach (Barnett et al., Outliers in Statistical Data, John Wiley & amp;; Sons, 3rd edition (1994).
The lines with significant enhanced root growth as determined by the method described above were designated as successes of phase 1. The successes of the Phase
1 were screened again in duplicate under the same conditions of the test. When one or both replicas of the phase
2 showed a significant difference of the medium, the line was then considered as a line with validated root architecture. The lines that were found again with limit values in at least one plate in phase 2 were subjected to a screening in phase 3 carried out internally, to validate the results obtained in phase 1 and phase 2. The results were validated in phase 3 through the use of Rootboot image analysis (as described above) and WinRHIZO®, as described below. Xa confirmation of modality in the same way as in the first round of screening. The T2 seeds were sterilized with 50% home bleach, .01% Triton X-100 solution and plated with the same medium as described in the first round of screening at a density of 10 seeds / plate. The plates were kept for three days at 4 ° C to stratify the seeds and were cultured at the same temperature and period of exposure to light as in the first experiment with light intensity of -160 pmol / m2 / s. The plates were placed vertically in the eight central positions of a shelf of 10 plates; the first and last position with empty plates. The shelves and plates inside a shelf were rotated every two days. It took two sets of images per plate. The first game was taken on day 14-16 when the main roots for most lines had reached the bottom of the plate, the second set of images was taken two days later after more lateral roots had been developed. The last set of images was used, usually, for data analysis. The root growth of these seedlings grown in vertical plates was analyzed with the inRHIZO® program (Regent Instruments Inc), an image analysis system designed specifically for root measurement. WinRHIZO® uses the contrast in pixels to distinguish the light root from the darker background. To identify the maximum number of roots without choosing the background, the classification in pixels was 150-170 and the filter characteristic was used to eliminate objects with a length / width ratio less than 10.0. The area in the plates analyzed was from the edge of the leaves of the plant to approximately 1 cm from the bottom of the plate. The exact same WinRHIZO® configuration and analysis area was used to analyze all the plates within a batch. The total root length score obtained from the WinRHIZO® for a plate was divided by the number of plants that had germinated and grown down to the middle of the plate. Three plates were grown for each line and their scores were averaged. Then this average was compared to the average of three plates with wild seeds grown at the same time.
Subsequently, Arabidopsis lines with activation labeling that were reconfirmed for having a higher root growth value compared to wild-type were used for the molecular identification of DNA contiguous to the insertion of T-DNA.
Example 3
Identification of genes with activation labeling
Genes contiguous to the T-DNA insert in lines with alteration in the root architecture are identified with the use of one or both of the following two standard procedures: (1) Asymmetric interlaced thermal PCR (PCR (TAIL), for short in English) (Liu et al., (1995), Plant J. 8: 457-63); and (2) SAIFF RCP (Siebert et al., (1995) Nucleic Acids Res. 23: 1087-1088). In lines with complex multimerized T-DNA inserts, both TAIL PCR and SAIFF PCR may be insufficient to identify candidate genes. In these cases, other methods may be used, which include inverse PCR, plasmid rescue and / or construction of the DNA library.
A successful result is when a single fragment of TAIL or SAIFF PCR contains a border sequence of T-DNA and a genomic sequence of Arabidopsis.
Once a tag of the genomic sequence contiguous to the T-DNA insert is obtained, the candidate genes are identified by the alignment for the Arabidopsis genome sequence available to the public.
Especially, the said gene closest to the enhancer elements 35S / BD of the T-DNA is a candidate for active genes.
To verify that an identified gene is truly close to a T-DNA and to exclude the possibility that the TAIL / SAIFF fragment is a chimeric cloning artifact, a diagnostic PCR is performed on the genomic DNA with an oligo in the T-DNA and a specific oligo for the candidate gene. The genomic DNA samples that provide a PCR product are interpreted as representing the T-DNA insert. This analysis also verifies a situation where more than one insertion event occurs on the same line, for example, if multiple different genomic fragments are identified in the TAIL and / or SAIFF PCR analyzes.
Example 4
Identification of the rep2 gene with activation labeling
A line that presents an alteration in the radicular architecture was also analyzed. The DNA was extracted from the line and the T-DNA insertion was found by ligature-mediated PCR (Siebert et al., (1995) Nucleic Acids Res. 23: 1087-1088) with the use of primers inside the left border of the T-DNA. Once a genomic sequence tag contiguous with the T-DNA insert was obtained, the candidate gene was identified by sequence alignment to the complete Arabidopsis genome. One of the identified insertion sites of line 126515 was identified as a chimeric insertion; The sequence of the left border of the T-DNA was determined at both ends of the T-DNA insertion. Even so, it was possible that the enhancer elements located near the right edge of the T-DNA are close enough to have an effect on the nearby candidate gene. In this case, it was assumed that the right border location was present at the insertion site and the two genes contiguous to the insertion site were chosen as candidates. In the case of line 126515, one of the genes closest to the 35S enhancers of the chimeric insertion was At5gl9590 (sec with ID No.: 48, NCBI GI NO: 15241137, unknown Arabidopsis thaliana protein), which encodes the REP2 protein (sec. with ident. no .: 42).
Example 5
Validation of a candidate Arabidopsis gene (AT5G19590) through transformation into Arabidopsis
The candidate gene AT5G19590 was transformed into Arabidopsis and overexpressed under the 35S promoter. If the same or a similar phenotype was observed in the transgenic line as in the paternal line with activation labeling, then the candidate gene was considered a validated "guide gene" in Arabidopsis. The AT5G19590 gene from Arabidopsis was directly tested due to its ability to enhance the architecture of radicular in Arabidopsis.
The Arabidopsis AT5G19590 cDNA was amplified by PCR with oligos introducing the attBl sequence (sec. With ID: 52), a consensus start sequence (CAACA) upstream of the ATG start codon and the first 24 nucleotides of the protein coding region of cDNA AT5G19590 (sec.with ident .: 49) and the sequence attB2 (sec.with ident .: 53) and the last 21 nucleotides of the coding region of proteins including the cDNA termination codon. With the use of the Invitrogen ™ Gateway® technology, a MultiSite Gateway® BP recombination reaction was performed with pDONR ™ / Zeo (Invitrogen ™, sec. With ID No.: 2). This process removes the bacterial lethal gene ccdB, as well as the chloramphenicol resistant gene (CAM) from pDONR ™ / Zeo and directionally clones the CPR product contiguous to the attBl sites (sec. With ident. No .: 52) and the attB2 sites (sec. with ID: 53) that create the PHP34600 input clone.
A binary vector based on the 16.8-kb T-DNA, called pBC-yellow (sec. With ident. No .: 4), was constructed with the 1.3-kb 35S promoter immediately upstream of the Cl conversion insert. Invitrogen ™ Gateway® containing the ccdB gene and the chloramphenicol resistant gene (CAM) contiguous to the attRl and attR2 sequences. The vector also contains a YFP marker under the control of the Rd29a promoter for the selection of transformed seeds.
With the use of Invitrogen ™ Gateway® technology, a MultiSite Gateway® LR recombination reaction was performed on the input clone containing the directionally cloned PCR product and the pBC-yellow. This allowed for rapid cloning. and directional gene AT5G19590 with the 35S promoter in pBC-yellow.
The 35Spromotor:: AT5G19590 expression construct was introduced into the wild Col-0 ecotype of Arabidopsis, using the same Agrobacterium-mediated transformation procedure described in Example 1.
Transgenic TI seeds were selected for the presence of the fluorescent marker YFP. The fluorescent seeds were subjected to the root architecture test following the procedure described in Example 2. The transgenic TI seeds were screened again through the use of 6 plates per construct. Two plates per shelf containing non-transformed Columbia seeds discarded from the fluorescent seed classification served as a control.
Six plaques per construct were statistically analyzed and a trend was detected between the number of plants growing on one plate and their average WinRHIZO® value. The values of WinRHIZO® were normalized for this trend and the value of the root corresponding to the construct was divided by the value of the wild root.
Example 6
Preparation of cDNA libraries;
Isolation and sequencing of cDNA clones
The cDNA libraries can be prepared by any of the various methods available. For example, cDNAs can be introduced into plasmid vectors by first preparing the cDNA libraries in Uni-ZAP ™ XR vectors in accordance with the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, CA). The Uni-ZAP ™ XR libraries are converted to plasmid libraries in accordance with the protocol provided by Stratagene. In the conversion, the cDNA inserts will be contained in the pBluescript plasmid vector. In addition, cDNA can be introduced directly into the precut Bluescript II SK (+) vectors (Stratagene) with the use of T4 DNA ligase (New England Biolabs), followed by transfection of the DH10B cells in accordance with the protocol of the manufacturer (GIBCO BRL Products). Once the cDNA inserts are in plasmid vectors, the plasmid DNAs are prepared from randomly selected bacterial colonies containing pBluescript recombinant plasmids or the inserted cDNA sequences are amplified by the polymerase chain reaction with the use of specific primers for sequences of vectors contiguous to the cDNA sequences inserted. The plasmid DNAs or DNAs of amplified inserts are sequenced in dye-initiator sequencing reactions to generate partial cDNA sequences (expressed sequence tags or "EST", see Adams et al., (1991) Science 252: 1651-1656 ). The resulting ESTs are analyzed with the use of a Model 377 fluorescent sequencer by Perkin Elmer.
The complete insert sequence (FIS) data is generated with the use of a modified transposition protocol. The clones identified by the FIS are recovered from conserved glycerin stores as single colonies and the plasmid DNAs are isolated via alkaline lysis. The isolated DNA templates are reacted with M13 direct and reverse nucleotides primed by the vector in a PCR-based sequencing reaction and loaded onto automated sequencers. Confirmation of clone identification is done by sequence alignment with the original EST sequence from which the FIS request is made.
The confirmed templates are transposed using the Primer Island transposition kit (PE Applied Biosystems, Foster City, CA) which is based on the Tyl transposable element of Saccharomyces cerevisiae (Devine and Boeke (1994) Nucleic Acids Res. 22: 3765-3772) . The in vitro transposition system randomly places unique binding sites throughout the population of large DNA molecules. Then the transposed DNA is used to transform the electrocompetent DH10B cells (Gibco BRL / Life Technologies, Rockville, MD) via electroporation. The transposable element contains an additional selectable marker (called DHFR; Fling and Richards (1983) Nucleic Acids Res. 11: 5147-5158) which allows double screening on agar plates only from subclones containing the integrated transposon. Randomly, multiple subclones of each transposition reaction are selected, the plasmid DNAs are prepared via alkaline lysis and the templates are subjected to sequencing (ABI Prism dye ReadyReaction mixture) out of the transposition event site, with the use of primers unique to the binding sites within the transposon.
Sequence information is collected (ABI Prism Collections) and assembled with the use of Phred and Phrap (Ewing et al. (1998) Genome Res. 8: 175-185; Ewing and Green (1998) Geno e Res. 5: 186 -194). Phred is a public domain program that rereads ABI sequence data, re-calls bases, assigns quality values and writes base calls and quality values to editable output files. The Phrap sequence assembly program uses these quality values to increase the accuracy of assembled sequence contigs. The assemblies are observed by the Consed sequence editor (Gordon et al. (1998) Genome Res. 8: 195-202).
In some clones, the cDNA fragment corresponds to the 3 '-terminal portion of the gene and does not cover the entire open reading frame. To obtain the information upstream one or two different protocols are used. The first of these methods results in the production of a DNA fragment containing a portion of the desired gene sequence while the second method results in the production of a fragment containing the complete open reading frame. Both methods use two PCR amplification runs to obtain fragments from one or more libraries. The libraries, sometimes, are chosen based on prior knowledge that the specific gene should be found in a specific tissue and, sometimes, are chosen randomly. The reactions to obtain the same gene can be carried out in several libraries in parallel or in a group of libraries. The groups of libraries are usually prepared with the use of 3 to 5 different libraries and are normalized to a uniform dilution. In the first round of amplification both methods use a specific primer of the vector (direct) corresponding to a portion of the vector located in the 5 '-terminal region of the clone together with a specific primer of the (reverse) gene. The first method uses a sequence complementary to a portion of the gene sequence already known, while the second method uses a specific primer of the gene complementary to a portion of the 3 'untranslated region (also called UTR, for its acronym in English ). In the second round of amplification, a subdivided set of primers is used for both methods. The resulting DNA fragment is ligated to the pBluescript vector with the use of a commercial kit and following the manufacturer's protocol. This kit is selected from the many available from several suppliers including Invitrogen ™ (Carlsbad, CA), Promega Biotech (Madison, WI), and Gibco-BRL (Gaithersburg, MD). The plasmid DNA is isolated by the alkaline lysis method and subjected to sequencing and assembly with the use of Phred / Phrap, as mentioned above.
Example 7
Identification of cDNA clones
The cDNA clones encoding REP2-like polypeptides can be identified by performing similarity searches of the BLAST program (tool for basic local alignment search); Altschul et al. , (1993) J. Mol. Biol. 215: 403-410; see also the explanation of the BLAST algorithm on the website of the National Center for Biotechnology Information in the National Library of Medicine of the National Institutes of Health) with the amino acid sequences contained in the "nr" database of BLAST (which includes all the non-redundant CDS translations of the GenBank, the sequences derived from the three-dimensional structure of Brookhaven Protein Data Bank, the latest release of the SWISS-PROT protein sequence database and the EMBL and DDBJ databases). The DNA sequences of the clones can be translated in all the reading frames and the similarity was compared with all the publicly available protein sequences contained in the "nr" database with the use of the BLASTX algorithm (Gish and States ( 1993) Nat. Genet 3: 266-272) provided by the CNIB. The polypeptides encoded by the cDNA sequences can be analyzed for similarity to all publicly available amino acid sequences contained in the "nr" database through the use of the BLASTP algorithm provided by the National Center for Biotechnology Information (NCBI). , for its acronym in English) . For convenience, the P value (probability) or the E value (expectation) of observing a match of a cDNA encoded sequence with a sequence contained in the search databases simply by chance as calculated by the BLAST are reported in this as "pLog" values, which represent the negative of the logarithm of the P value or E value reported. Therefore, the higher the pLog value, the greater the probability that the cDNA encoded sequence and the "hit" of BLAST represent homologous proteins.
The EST sequences can be compared to the Genbank database as described above. ESTs containing sequences with more than 5 or 3 primers can be found with the use of the BLASTn algorithm (Altschul et al., (1997) Nucleic Acids Res. 25: 3389-3402.) Compared to the registered database of Du Pont comparing nucleotide sequences that share common or overlapping regions of homologous sequences. Where there are common or overlapping sequences between two or more fragments of nucleic acids, the sequences can be assembled into a single sequence of contiguous nucleotides, thus extending the original fragment either in the direction of the primer 5 or 3. Once the primer more 5 is identified, its entire sequence can be determined by the complete sequencing of the insert as described above. Homologous genes belonging to different species can be found by comparing the amino acid sequence of a known gene (either from a registered source or from a public database) against an EST database with the use of the tBLASTn algorithm. The tBLASTn algorithm compares a query formed by amino acids compared to a translated nucleotide database in the 6 reading frames. This search allows differences in the use of nucleotide codons between different species and for codon degeneration.
Example 8
Characterization of the clones that code for cDNA
Polypeptides similar to REP2
The cDNA libraries representing the mRNAs of various tissues of Canna edulis (Cane), Momordica charantia (bitter cucumber), Brassica (mustard), Cygopsis tetragonoloba Cguar), Zea mays (corn), Oryza sativa (rice), Glycine max ( soybean), Helianthus annuus (sunflower) and Triticum aestivum (wheat) were prepared and the cDNAs encoding the REP2 polypeptides were identified. The characteristics of the libraries are described below.
Table 3
Genomes of cane cDNA, bitter cucumber, mustard, guar rice, soy, sunflower and wheat
Cloth Weaving Clone Library
Corn, meristem, of the stem. Identify
cmstls. pk003.p21a cmstls the genes that are. express in the region
: meristematic fis inside an internode.
my. ctaln.pk0015.b and Myriad project reports
12
Corn silk pollinated and not
pollinated, in groups, of cfp2n.pk064.114: f cfp2n
Total length, enriched and is
normalized
The pericarp library of 21 DAP is
necessary to identify new
genes related to the cell wall
cpplc .pk003.123: f cp lc (for example, xilan synthase) that
is specifically expressed during the
Rapid accumulation of arabinoxylan in
this tissue.
Seed in development of daisy
dmslc dmslc. African pk001.el6 (Dimorphotheca sinuata).
Clone Clone Library
Immature buds of the mutant line
deficient in the Rf gene of Cañóla,
ebb2c 02SM5. Isolation of ebb2c .pk008.k7 genes involved in the restoration of
CMS
Beet, sprout-specific genes
ebslc ebslc.pk003.n21 and phloem
Seeds in development
Chyrsobalanus icaco (icaco) that
ecilc accumulate large quantities of acids ecilc .pk007. i2 fatty keto and fatty acids with links
double conjugates.
Rhizomes in ginger development
ecrlc (starch of Turmeric zedoaria, aka ecrlc. k012.dl3 shoti)
sunflower plants
hsolc hsolc .pkOlO. g9 transgenic-oxalate oxidase
Guar seeds (Cyamopsis
ldslc ldslc. k015.17 tetragonoloba) | cultivated at 15 DAF
Cotyledon in soybean germination
sgc6c (Glycine max L., Wye) (all yellow; sgc6c .pkOOl.
16-26 DAG).
srl Soya root srl .pk0078.a4 vpllc Grape (Vitis sp.) Seedlings in vitro vpllc. pk007.b20
Seed in development of margarita dmslc .pkOOl. el6: dmslc
African (Dimorphotheca sinuata). fis
Cloth Weaving Clone Library
Immature buds of the mutant line
deficient in the Rf gene of Cañóla,
ebb2c.pk008.k7: f ebb2c 02SM5. Isolation of genes
is involved in the restoration of
CMS
Cotyledon in soybean germination
sgc6c .pkOOl. f21: sgc6c (Glycine max L., Wye) (all yellow;
fis
16-26 DAG).
Beet, sprout-specific genes ebslc .pk003.n21: ebslc
and phloem fis
Seeds in development
Chyrsobalanus icaco (icaco) that
ecilc .pk007. i2: Easy to accumulate large amounts of acids
is fatty keto and fatty acids with
double conjugated links.
Rhizomes in ginger development
ecrlc.pk012.dl3: ecrlc (Starch of Turmeric zedoaria aka.
fis shoti)
vpllc .pk00 .b20: vpllc Grape (Vitis sp.) Seedlings in vitro
fis sunflower plants sunflower hsolc
transgenic-oxalate oxidase transgenic-oxa lato oxidase srl Soybean root srl .pk0078. a4: fis The search for BLASTX through the use of the EST sequences of the clones listed in Table 1 revealed similarity of the polypeptides encoded by the cDNAs with the polypeptides similar to the REP2 of Oryza sativa (GI No. 115463429, 125552383, 115438148, and 125533926 corresponding to the sec. With ident. No .: 43, 44, 45, and 46, respectively) and with Polpulus trichocarpa (GI No. 118487434 corresponding to the sec. With ident. No .: 47) . Table 4 shows the BLAST results for the individual ESTs ("EST"), the sequences of the entire cDNA inserts comprising the indicated cDNA clones ("FIS"), the grouped contig sequences of two or more EST, FIS or PCR sequences ("Contigo"), or sequences that encode an entire or functional protein derived from an FIS or a you ("CGS"):
Table 4
BLAST results and percentage of identity sequences encoding polypeptides
Polypeptide homologs similar to a REP2
Sequence State GI No. of pLog of% of
CNIB BLAST identity
Value
cmstls.pk003.p21a: f SCG 115463429 51 59.5
is (Rice)
Sec. With no. of (sec.
ident : 14 no. from
ident : 61)
Sequence State GI No. of pLog of% of
CNIB BLAST identity
Value
cpplc .pk003.123: fis SCG 125533926 43 58.0
Sec. With no. of rice)
ident : 20 Sec. with no.
of ident. : 61
ldslc.pk015.17 EST 118487434 49 60.7
Sec. With no. from
ident : 22
dmslc .pko01. el6: fis SCG 118487434 51 68.7
Sec. with no. of Sec. with no.
ident : 24 of ident. : 61
ebb2c .pk008.k7: fis SCG 15241137 56 82.0
Sec. With no. of Sec. with no.
ident : 26 of ident. : 66
sgc6c .pkO01. f21: fis SCG 118487434 50 60.7
Sec. With no. of Sec. with no.
ident : 28 of ident. : 61
ebslc .pk003. n21: fis SCG 118487434 44 59.3
Sec. With no. of Sec. with no.
ident : 30 of ident. : 64
ecilc .pkO07. i2: fis SCG 118487434 53 71.3
Sec. With no. of Sec. with no.
ident : 32 of ident. : 66
ecrlc .pk012. di3: fis SCG 15241137 41 52.7
: fis Sec. with
Sec. With no. of no. from
ident : 34 ident. : 64
Sequence State GI No. of pLog of% of
CNIB BLAST identity
Value
vpllc.pk007.b20: fis SCG 118487434 48 63.3
Sec. With no. of Sec. with
ident : 36 no. from
ident : 62
hsolc .pkOlO .g9: fis SCG 118487434 46 64.7
Sec. With no. of Sec. with
ident : 38 no. from
ident : 61
srl .pk0078. a4: fis SCG 118487434 51 61.3
Sec. With no. of Sec. with
ident : 40 no. from
ident : 62
Figures 1A-1B present an alignment of the amino acid sequence that is set forth in sec. with no. Ident .: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, and 42 and the amino acid sequence of the REP2 polypeptides of Oryza sativa (GI no. 115463429, 125552383, 115438148, and 125533926 corresponding to the ident. Sec .: 43, 44, 45, and 46, respectively) and for Polpulus trichocarpa (GI No. 118487434 corresponding to the sec. With ident. .: 47). Figure 2 presents percentage values of sequence identity and divergence for each sequence pair presented in Figures 1A-1B.
Sequence alignments and percent identity calculations were performed with the use of the Megalign program from the integrated LASERGENE bioinformatics package (ADNSTAR Inc., Madison, WI). The multiple alignment of the sequences was carried out with the use of the Clustal alignment method (Higgins and Sharp (1989) CABIOS 5: 151-153) with the predetermined parameters (PENALTY OF INTERRUPTION = 10, PENALTY OF INTERRUPTION LENGTH 10). The default parameters for alignments in pairs with the use of the Clustal method were KTUPLE 1, PENALTY OF INTERRUPTION3, WINDOW = 5 and DIAGONALS SAVED = 5.
The sequence alignments and BLAST values and probabilities indicate that the nucleic acid fragments comprising the instant cDNA clones encode REP2-like polypeptides.
Table 5
BLAST results for sequences encoding polypeptides homologous to REP2 polypeptides
Sequence State Reference pLog of% of
BLAST identity Value
cmstls .pk003.p21a: fis SCG sec. with no. of 83 97.1 sec. connúm. of ident. : ident : 186191 in
14 patent no.
US2004214272-A1
Sequence State Reference pLog of% of
BLAST identity Value
my.ctaln.pk0015.bl2 SCG sec. with no. 42 92.2 sec. with no. Ident :
16 326948 in
The patent
no.
US2004214272- Al
Cfp2n.pk064.114: fis SCG sec. with no. 54.98.7 sec. with no. of ident. : from ident :
18 191053 in
The patent
no.
US2004214272- Al
cpplc.pk003.123: fis FIS sec. with no. 71 100.0 sec. with no. Ident :
20 311140 in
US2004214272- Al.
ldslc.pk015.17 SCG sec. with no. 68 100 sec with no. of ident. : from ident :
22 6482 in
US2007277269
dmslc.pk001.el6: fis SCG sec. with no. 46.97.8 sec. with no. of ident. : from ident :
24 62116 in
US2007061916
Sequence State Reference pLog of% of
BLAST identity Value
ebb2c .pk008. k7: fis SCG sec. with no. 57 100 sec with no. of ident. : from ident :
26 6992 in
The patent
no.
US2006107345- Al
Sgc6C.pk001. f21: fÍS EST sec. with no. 85 95.6 sec. with no. Ident :
28 6482 in
US2007277269
ebslc.pk003.n21: fis SCG sec. with no. 45 97.3 sec. with no. Ident :
30 62116 in
US2007061916
ecilc.pk007 i2: fis SCG sec. with no. 51 91.3 sec. with no. Ident :
32 62116 in
US2007061916
ecrlc .pkO12. dl3: fis: fis SCG sec. with no. 40 96.9 sec. with no. Ident :
34 62116 in
US2007061916
vpllc.pk007.b20: fis SCG sec. with no. 49 79.8 sec. with no. Ident :
36 62116 in
US2007061916
Example 9
Preparation of an expression vector for plants With a homolog of the Arabidopsis guide gene (AT5G19590) The sequences homologous to the guide gene of rep2 can be identified with the use of sequence comparison algorithms, such as BLAST (tool for local alignment search Altschul et al., J. Mol. Biol. 215: 403-410 (1993), see also the BLAST algorithm explanation on the National Center for Biotechnology Information website at the National Library of Medicine of the National Institutes of Health). Sequences similar to a rep2 homologues, such as those described in Example 8, can be amplified by PCR by any of the following methods.
Method 1 (based on RNA): If the information of the 5 'and 3' sequence for the protein coding region of a REP2 homologue is available, the gene-specific primers can be designated as outlined in Example 5. The RT-PCR can be used with the plant RNA to obtain a nucleic acid fragment containing the coding region of REP2 proteins contiguous to the attBl sequences (sec. With ident. No .: 52) and attB2 (sec. Ident. no .: 53). The primer may contain a Kozak consensus sequence (CAACA) upstream of the start codon.
Method 2 (based on DNA): Alternatively, if a cDNA clone is available for a gene encoding a homologue of the REP2 polypeptide, the complete cDNA insert (containing the 5 'and 3' non-coding regions) can be amplified by CPR. Direct and reverse primers can be designed that contain either the attBl sequence and the specific sequence of the vector preceding the cDNA insert or the attB2 sequence and the specific sequence of the vector following the cDNA insert, respectively. To clone a cDNA insert into the pBluescript SK + vector, you can use the direct primer VC062 (sec with ID number: 54) and the reverse primer VC063 (sec with ID number: 55) .
Methods 1 and 2 can be modified in accordance with procedures known to a person skilled in the art. For example, the primers of method 1 may contain restriction sites instead of attBl and attB2 sites, for the subsequent cloning of the PCR product into a vector containing attBl and attB2 sites. In addition, method 2 may require the amplification of a cDNA clone, a lambda clone, a BAC clone or genomic DNA.
A PCR product obtained by any of the above methods can be combined with the Gateway® donor vector, such as pDONR ™ / Zeo (Invitrogen ™, sec with Ident #: 2) or pDONR ™ 221 (Invitrogen ™ , sec. with ident. no .: 3) through the use of a recombination reaction BP. This process removes the lethal bacterial gene ccdB, as well as the chloramphenicol resistant gene (CAM) from pDONR ™ 221 and directionally clones the PCR product contiguous to the attBl and attB2 sites to create an input clone. With the use of Invitrogen ™ Gateway® Clonase ™ technology, the gene similar to rep2 homologue of the input clone can be transferred to a suitable target vector to obtain an expression vector for plants for use with Arabidopsis, corn and soybeans, as pBC-Yellow (sec. with ID number: 4), PHP27840 (sec. with ID number: 5) or PHP23236 (sec. with ID number: 6), to obtain a vector of expression for plants to be used with Arabidopsis, soybean and corn, respectively.
Alternatively, a MultiSite Gateway® LR recombination reaction can be performed between multiple input clones and a suitable target vector to create an expression vector. An example of this procedure is detailed in Example 14A, which describes the construction of corn expression vectors for the transformation of corn lines.
Example 10
Preparation of soybean expression vectors and transformation of soybean with validated Arabidopsis guide genes and homologues of these
The soybean plants can be transformed to overexpress the validated Arabidopsis gene (AT5G19590) and the corresponding homologs of the various species to examine the resulting phenotype.
The input clones described in Examples 5 and 9 can be used to directionally clone each gene in the vector PHP27840 (sec connúm ident: 5) in such a way that the expression of the gene is under control of the promoter SCPlr.
Soy bean embryos can be transformed with the expression vector comprising sequences encoding the instant polypeptides.
To produce somatic embryos, cotyledons, 3-5 mm in length separated from the sterilized surface, the immature seeds of cultivar A2872 from soybean can be grown in light or dark at 26 ° C on an appropriate agar medium for 6-10 weeks. Somatic embryos, which produce secondary embryos, are then separated and placed in a suitable liquid medium. After repeated selection for groups of somatic embryos that multiply as embryos pre-mature in globular phase, the suspensions are preserved as described below.
The embryogenic suspension cultures of soybeans can be maintained in 35 ml of liquid medium in a rotary shaker of 150 rpm, at 26 ° C with fluorescent lights with a schedule of 16: 8 hours day / night. The cultures are subcultured every two weeks by inoculation, approximately 35 mg of tissue in 35 ml of liquid medium.
Embryogenic suspension crops of soybean can be transformed by the particle bombardment method (Klein et al. (1987) Nature (London) 327: 70-73, United States Patent No. 4,945,050). A PDS1000 / HE instrument from DuPont Biolistic ™ (helium retro-fit) can be used for these transformations.
A selectable marker gene that can be used to facilitate the transformation of soybeans is a chimeric gene composed of the 35S promoter of cauliflower mosaic virus (Odell et al. (1985) IVature 313: 810-812), the gene for hygromycin phosphotransferase of plasmid pJR225 (from E. coli; Gritz et al., (1983) Gene 25: 179-188) and the 3 'region of the nopaline synthase gene of the T plasmid of Agrobacterium turnefaciens T-DNA. Another selectable marker gene that can be used to facilitate the transformation of soybean is an acetolactate synthase (ALS) gene resistant to soybean or Arabidopsis herbicides. ALS is the first common enzyme in the biosynthesis of branched-chain amino acids valine, leucine and isoleucine. It has been identified that mutations in ALS impart resistance to some or all three classes of ALS inhibitors (U.S. Patent No. 5,013,659, the entire contents of which are incorporated herein by reference). The expression of the herbicide-resistant ALS gene can be under the control of the SAM promoter synthetase (U.S. Patent Application No. US-2003-0226166-A1, the entire contents of which are incorporated herein by reference).
At 50 μ? of a suspension of 60 mg / ml of 1 μ gold particles ?? is added (in order): 5 μ? of DNA (1 μ? / μ?), 20 μ? of spermidine (0.1 M) and 50 μ? of CaC12 (2.5 M). After the particle preparation is mixed for three minutes, it is centrifuged in a microcentrifuge for 10 seconds and the supernatant is removed. Then the DNA covered particles are washed once in 400 μ? of 70% ethanol and resuspended in 40 μ? of anhydrous ethanol. The DNA / particle suspension can be sonicated three times for one second each. Then 5 μ? of the gold particles covered with DNA in each disk of the macrocarrier.
Approximately 300-400 mg of a two-week suspension culture is placed in an empty 60x15 mm petri dish and the remaining liquid from the tissue is removed with a pipette. For each transformation experiment, approximately 5-10 tissue plates are usually bombarded. The breaking force of the membrane is adjusted to 7.6 MPa (1100 psi) and the chamber evacuated under vacuum with 94.8 kPa (28 inches of mercury). The fabric is placed approximately 8.9 cm (3.5 inches) from the retention screen and is bombarded three times. After the bombardment, the tissue can be divided in half and can be placed back into the liquid to grow it as described above.
Five to six days after the bombardment, liquid media can be exchanged with fresh media and eleven to twelve days after bombardment with fresh media containing 50 mg / ml hygromycin. These selective media can be refreshed weekly. Seven to eight weeks after the bombardment, transformed green tissue can be seen growing from non-transformed necrotic embryo groups. The isolated green tissue is extracted and inoculated into individual flasks to generate new embryogenic suspension cultures, transformed and propagated by cloning. Each new line can be treated as an independent transformation event. These suspensions can be subcultured and maintained as groups of immature embryos or can be regenerated into whole plants by the maturation and germination of individual somatic embryos.
The enhanced root architecture can be determined in soybeans by growing the plants in soil and washing the roots before analysis of the total root mass with WinRHIZO®.
Then the transformed soybean plants with validated genes can be analyzed to study the agronomic characteristics in relation to control or reference plants. For example, the efficiency of nitrogen use, production enhancement and / or stability under various environmental conditions (eg, nitrogen limiting conditions, drought, etc.).
Example 11
Transformation of maize with Arabidopsis guide genes validated by particle bombardment.
Corn plants can be transformed to overexpress a validated Arabidopsis guiding gene or corresponding homologs from several species to examine the resulting phenotype.
The Gateway® input clones described in Example 5 can be used to addressally clone each gene in a corn transformation vector. The expression of the gene in corn may be under the control of a constitutive promoter, such as the ubiquitin corn promoter (Christensen et al., Plant Mol. Biol. 12: 619-632 (1989) and Christensen et al., Plant. Mol. Biol. 18: 675-689 (1992)).
The recombinant DNA construct described above can be introduced into corn cells by the following procedure. Immature maize embryos can be separated from developing cariopses derived from crosses of the maize inbred lines H99 and LH132. Embryos are isolated ten to eleven days after pollination when they are 1.0 to 1.5 mm in length. The embryos are then placed with the shaft side down and in contact with N6 medium solidified with agarose (Chu et al., Sci. Sin. Peking 18: 659-668 (1975)). The embryos are kept in the dark at 27 ° C. Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoid suspensory structures proliferates from the scutellum of these immature embryos. The embryogenic callus isolated from the primary explant can be grown in N6 medium and subcultured in this medium every two or three weeks.
The plasmid, p35S / Ac (obtained from Dr Peter Eckes, Hoechst Ag, Frankfurt, Germany), can be used in transformation experiments to determine a selectable marker. This plasmid contains the pat gene (see European Patent Publication No. 0 242 236) which codes for phosphinothricin acetyl transferase (PAT). The enzyme PAT confers resistance to herbicidal inhibitors of glutamine synthetase, such as phosphinotricin. The pat gene in p35S / Ac is under the control of the 35S promoter of the cauliflower mosaic virus (Odell et al., Nature 313: 810-812 (1985)) and the 31 region of the nopaline synthase gene of the T-DNA of the plasmid Ti of Agrobacterium turnefaciens.
The particle bombardment method (Klein et al., Nafcure 327: 70-73 (1987)) can be used to transfer genes to callus culture cells. In accordance with this method, the gold particles (1 m in diameter) are coated with DNA using the following technique. 10 g of plasmid DNA is added to 50 μ? of a suspension of gold particles (60 mg per ml). Calcium chloride (50 μl of a 2.5 M solution) and spermidine free base (20 μl of a 1.0 M solution) are added to the particles. The suspension is vortexed during the addition of these solutions. After ten minutes, the tubes are centrifuged briefly (5 s at 15,000 rpm) and the supernatant is removed. The particles are resuspended in 200 μ? of absolute ethanol, centrifuged again and the supernatant was removed. The ethanol rinsing is done again and the particles are resuspended in a final volume of 30 μ? of ethanol. An aliquot (5 μm) of gold particles covered in DNA can be placed in the center of a Kapton ™ flying disc (Bio-Rad Labs). Afterwards, the particles are accelerated in the corn tissue with a Biolistic® PDS-1000 / He (Bio-Rad Instruments, Hercules CA), with a helium pressure of 6.9 Pa (1000 psi), a gap distance of 0.5 cm and a flight distance of 1.0 cm.
For the bombardment, the embryogenic tissue is placed on filter paper on the N6 medium solidified with agarose. The tea is placed as a thin lawn and a circular area about 5 cm in diameter is covered. The petri dish containing the fabric can be placed in the PDS-1000 / He chamber approximately 8 cm from the termination screen. The air in the chamber is then evacuated under vacuum with 94.8 kPa (28 inches of Hg). The macrocarrier accelerates with an expansive wave of helium with the use of a rupture membrane that breaks when the He pressure in the tube reaches 6.9 MPa (1000 psi).
Seven days after the bombardment, the tissue can be transferred to the N6 medium containing bialaphos (5 mg per liter) and lacks casein or proline. The tissue continues to grow slowly in this medium. After two additional weeks, the tissue can be transferred to fresh N6 medium containing bialaphos. After six weeks, areas of approximately 1 cm in diameter of the callus that actively grow on some of the plates containing the medium supplemented with bialaphos can be identified. These calluses can continue to grow when subcultured in the selective medium.
Plants can be regenerated from the transgenic callus by first transferring tissue groups to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to the regenerative medium (Fromm et al., Bio / 'Technology 8: 833-839 (1990)).
The T0 transgenic plants can be regenerated and their phenotype can be determined following the HTP procedures. IT seeds can be collected.
IT plants can be grown and analysis of phenotypic changes can be made. The following parameters can be quantified with the use of image analysis: the plant area, volume, growth rate and color analysis can be collected and quantified. The expression constructs resulting from the alteration in the radicular architecture or any other of the agronomic characteristics listed above, in comparison with suitable control plants, can be considered evidence that the Arabidopsis guiding gene functions in maize to alter the radicular architecture or the architecture of the plant.
In addition, a recombinant DNA construct containing a validated Arabidopsis gene can be introduced into a corn line, either by direct transformation or introgression from a separately transformed line.
Transgenic plants, either inbred or hybrid, can be subjected to more powerful experiments based on the field to study the root or plant architecture, the production enhancement and / or the resistance to the location of the root under various environmental conditions (for example, variations in water and nutrient availability).
Subsequent production analysis can also be performed to determine if plants containing the validated Arabidopsis guiding gene have an improvement in production yield when compared to control (or reference) plants that do not contain the guiding gene of validated Arabidopsis. Plants containing the validated Arabidopsis guiding gene would improve production relative to control plants, preferably 50% less loss of production under adverse environmental conditions or would have an increase in production relative to control plants under various environmental conditions.
Example 12
Electroporation of Agrobacterium tumefaciens LBA4404 Electroporation competent cells (40 μ?), Such as Agrobacterium tumefaciens LBA4404 (containing PHP10523), are thawed on ice (20-30 min). PHP10523 contains VIR genes for the transfer of T-DNA, a plasmid replication origin with a low copy number of Agrobacteria, a tetracycline resistance gene and an eos site for the biomolecular recombination of DNA in vivo. Meanwhile, the electroporation cuvette is cooled in ice. The electroporator configuration was adjusted to 2.1 kV.
An aliquot of DNA (0.5 μ? Of JT parent DNA (U.S. Patent No. 7,087,812) at a concentration of 0.2 xg - 1.0 g in low salt regulator or twice distilled H20) is mixed with the cells of Agvrojacterium thawed while kept on ice. The mixture is transferred to the bottom of the electroporation cuvette and is kept at rest for 1-2 min. The cells are electroporated (electroporator 2510 of Eppendorf) by pressing the "Pulse" button twice (ideally, until a pulse of 4.0 msec is reached). Subsequently, a 0.5 ml 2xYT medium (or a SOC medium) is added to the cuvette and transferred to a 15 ml Falcon tube. The cells are incubated at 28-30 ° C, 200-250 rpm for 3 h.
Aliquots of 250 μ? they were sprayed on plates no. 30B (YM + 50 g / ml spectinomycin) and incubated 3 days at 28-30 ° C. To increase the number of transformants one of the two optional stages can be carried out:
Option 1: Coat the plates with 30 μ? of rifampicin
15 mg / ml. LBA4404 has a chromosomal resistance gene for rifampicin. This additional selection eliminates some of the contaminant colonies observed when more deficient preparations of competent cells of LBA4404 are used.
Option 2: Perform two replications of the electroporation to compensate the most deficient electrocompetent cells.
Identification of transformants:
Four independent colonies are selected and dispersed in a minimum medium AB with 50 mg / ml spectinomycin plates (medium No. 12S) to isolate the single colonies. Plates were incubated at 28 ° C for 2-3 days.
A single colony is chosen for each putative cointegrate and inoculated with 4 ml of num. 60A with 50 mg / 1 of spectinomycin. The mixture is incubated for 24 h at 28 ° C with shaking. The plasmid DNA of the 4 ml of culture is isolated with the use of the Qiagen mini-preparation + optional PB wash. The DNA was eluted in 30 μ ?. Aliquots of 2 μ? to electroporate 20 μ? of DHlOb + 20 μ? of ddH20 according to the above.
Optionally, a 15 μ aliquot can be used? to transform 75-100 μ? of the Invitrogen ™ Library Efficiency DH5a.
The cells were sprayed onto plates of LB medium plus 50 mg / ml spectinomycin (medium No. 34T) and incubated at 37 ° C overnight.
Three to four independent colonies are chosen for each putative cointegrate and inoculated with 4 ml of 2xYT (No. 60A) with 50 g / ml of spectinomycin. Cells are incubated at 37 ° C overnight with shaking.
The plasmid DNA is isolated from the 4 ml of culture with the use of the mini-preparation of QIAprep® with optional PB washing (washing in 50 μL) and using 8 μ? for digestion with Salí (with the use of parental JT and PHP10523 as controls).
Three more digestions are performed with the use of the restriction enzymes BamHI, EcoRI and HindIII for 4 plasmids representing 2 putative cointegrates with SalI correct digestion pattern (with the use of parental DNA and PHP10523 as controls). Electronic gels are recommended for comparison.
Alternatively, for high productivity applications, such as described for gas lines derived from Gaspe Bay Flint (Examples 15-17), instead of evaluating the resulting cointegrated vectors by restriction analysis, three colonies can be used simultaneously for the infection stage, as described in Example 13.
Example 13
Agrobacterium-mediated corn transformation Maize plants can be transformed to overexpress a validated Arabidopsis guiding gene or corresponding homologs from several species to examine the resulting phenotype.
The transformation of corn mediated by Agrobacterium is carried out practically as described by Zhao et al. , in Metí .. Mol. Biol. 318: 315-323 (2006) (see also Zhao et al., Mol. Breed 8: 323-333 (2001) and U.S. Patent No. 5,981,840 issued November 9, 1999, incorporated in the present as a reference). The transformation process requires bacterial inoculation, cocultivation, rest, selection and plant regeneration.
1. Preparation of immature embryos
The immature embryos are separated from the cariopses and placed in a 2 ml microtube containing 2 ml of PHI-A medium.
2. Agrobacterium infection and embryo cocultivation 2.1 Stage of infection
The PH.I-A medium is removed with a 1 ml micropipette and 1 ml of Agrobacterium suspension is added. The tube is carefully inverted to mix. The mixture is incubated for 5 min at room temperature.
2. 2 Stage of cocultivation
The Agrobacterium suspension is removed from the infection stage with a 1 ml micropipette. With the use of a sterile spatula, the embryos are detached from the tube and transferred to a plate of PHI-B medium in a 100x15 mm petri dish. The embryos are oriented with their axis down on the surface of the medium. The plates with the embryos are grown at 20 ° C, in the dark, for 3 days. L-cysteine can be used in the coculture phase. With the standard binary vector, the co-culture medium provided with 100-400 mg / l L-cysteine is critical for recovering stable transgenic events.
3. Selection of putative transgenic events
For each plate of PHI-D medium in a petri dish of 100x15 mm, 10 embryos are transferred, keeping the orientation and the dishes are sealed with Parafilm. The plates are incubated in the dark at 28 ° C. Putative active growth events, such as pale yellow embryonic tissue, are expected to be visible in 6-8 weeks. Embryos that do not produce events can be brown and necrotic and the low growth of friable tissue is evident. The putative transgenic embryonic tissue is subcultured in fresh PHI-D plates at 2-3 week intervals, depending on the growth index. The events are recorded.
4. Regeneration of plants T0
The embryonic tissue propagated in PHI-D medium is subcultured in PHI-E medium (maturation medium of somatic embryos); in 100x25 mm Petri dishes and incubated at 28 ° C, in the dark, until the somatic embryos mature, for approximately 10-18 days. Mature and individual somatic embryos with well defined scutellum and coleoptile are transferred to the germination medium of PHI-F embryos and incubated at 28 ° C in the light (approximately 80 μ? Of the white light lamps or equivalent fluorescent lamps) . In 7-10 days, the regenerated plants of approximately 10 cm in height are placed in pots in a horticultural mixture and hardened with the use of standard horticultural methods.
Means for plant transformation
1. PHI-A: 4 g / 1 of basal salts CHU, 1.0 ml / 1 of vitamin mixture of Eriksson 1000X, 0.5 mg / 1 of thiamine HCL, 1.5 mg / 1 of 2,4-D, 0.69 g / 1 of L -proline, 68.5 g / 1 sucrose, 36 g / 1 glucose, pH 5.2. Add 100 μ? of acetosyringone, sterilized with filter before use.
2. PHI-B: PHI-A without glucose, 2,4-D increased to 2 mg / 1, sucrose reduced to 30 g / 1 and supplemented with 0.85 mg / 1 silver nitrate (sterilized with filter), 3.0 g / 1 of gelrite, 100 μ? of acetosyringone '(sterilized with filter), 5.8.
3. PHI-C: PHI-B without gelrite or acetosyringone, 2,4-D reduced to 1.5 mg / 1 and supplemented with 8.0 g / 1 agar, 0.5 g / 1 deregulator Ms-morpholino ethane sulfonic acid (MES), 100 mg / 1 carbenicillin (sterilized with filter).
4. PHI-D: PHI-C supplemented with 3 mg / 1 of bialaphos
(sterilized with filter).
5. PHI-E: 4.3 g / 1 of Murashige and Skoog (MS) salts, (Gibco, BRL 11117-074), 0.5 mg / 1 of nicotinic acid, 0.1 mg / 1 of thiamine HC1, 0.5 mg / 1 of pyridoxine HC1 , 2.0 mg / 1 glycine, 0.1 g / 1 myo-inositol, 0.5 mg / 1 zeatin (Sigma, cat.
Z-0164), 1 mg / l of indole acetic acid (AIA), 26.4 pg / l of abscisic acid (ABA), 60 g / 1 of sucrose, 3 mg / l of bialaphos (sterilized with filter), 100 mg / 1 carbenicillin (sterilized with filter), 8 g / l of agar, pH 5.6.
6. PHI-F: PHI-E without zeatin, AIA or ABA; sucrose reduced to 40 g / 1; agar replacement with 1.5 g / 1 of gelrite; pH 5.6.
Plants can be regenerated from the transgenic callus by first transferring tissue groups to N6 medium supplemented with 0.2 g per liter of 2,4-D. After two weeks the tissue can be transferred to the regenerative medium (from et al (1990) Bio / Technology 8: 833-839).
The phenotypic analysis of the T0 and TI transgenic plants can be performed.
IT plants can be analyzed for phenotypic changes. With the use of image analysis, IT plants can be analyzed for phenotypic changes in the plant area; the volume, the growth rate and the color analysis can be taken several times during the growth of the plants. The alteration in the radicular architecture can be analyzed as described in Example 20.
The subsequent analysis of the alterations in the agronomic characteristics can be carried out to determine if the plants containing the validated Arabidopsis guide gene have an improvement of at least one agronomic characteristic, when compared with the control (or reference) plants that do not contain the validated Arabidopsis guide gene. Alterations can also be studied under various environmental conditions.
The expression constructs that result in a significant alteration in the radicular architecture are considered evidence that the Arabidopsis gene in maize works to alter the radicular architecture.
Example 14A
Construction of corn expression vectors with the Arabidopsis guide gene (At5gl9590) through the use of Agrobacterium-mediated transformation
The corn expression vectors can be prepared with the Arabidopsis REP2 gene (At5gl9590) under the control of the NAS2 promoter (sec. With ident. No .: 57) and GOS 2 (sec. With ident. : 58). The terminator was PINII (sec. With ident. No .: 61).
With the use of Invitrogen ™ Gateway® technology the entry clone, created as described in Example 5, PHP 34600, containing the Arabidopsis REP2 gene (At5gl9590) can be used in separate LR Gateway® reactions with:
1) the entry clone of the constitutive promoter GOS2 of maize (PHP28408, sec with ident #: 11) and the input clone of the PINII terminator (PHP20234, sec. With ident. No .: 9) in the target vector PHP28529 (sec. with ID number: 10). The resulting vector is called PHP29306.
2) the entry clone of the ÑAS2 promoter of the maize root (PHP22020, sec with ident #: 12) and the input clone of the PINII terminator (PHP20234, sec. With ident. No .: 9) in the target vector PHP28529 (sec. with ident. no .: 10). The resulting vector is called PHP29307.
The target vector PHP28529 also added to each of the final vectors (PHP29306 and PHP29307) a:
1) Promoter cassette RD29A:: yellow fluorescent protein:: Pinll terminator for the classification of Arabidospis seeds
2) ubiquitin promoter cassette:: moPAT / red fluorescent protein fusion:: PINII terminator for transformation selection and Z. mays seed classification.
Example 14B
Preparation of corn expression constructs containing the rep2 of Arabidopsis and its homologs.
The rep2 gene of Arabidopsis and the corresponding homologs of corn and other species (Table 1) can be transformed into corn lines with the use of the procedures described in Examples 5A and 14A. The expression vectors of maize with the rep2 gene of Arabidopsis and the corresponding homologs of maize and other species (Table 1) can be prepared as described in Examples 5A and 14A. Addition to the promoter GOS2 or AS2, other promoters, such as but not limited to, the ubiquitin promoter, the S2A and S2B promoter, the R00TMET2 maize promoter, the Cyclo corn, the CR1BI0, the CRWAQ81 and the ZRP2. 4447 corn are useful for directing the expression of the rep2 gene and genes similar to rep2 in corn. In addition, a wide variety of terminators, such as, but not limited to, the PINII terminator, can be used to achieve expression of the gene of interest in corn.
Example 14C
Transformation of maize lines with the Arabidopsis guide gene (At5gl9590) and the corresponding homologs from other species with the use of Agrobacterium-mediated transformation.
Then the final vectors (vectors for expression in maize, Examples 14A and B) can be electroporated separately in LBA4404 Agrobacterium containing PHP10523 (sec. With ident. No .: 7, Komari et al Plant J 10: 165- 174 (1996), CNIB GI: 59797027) to create the cointegrated vectors for corn transformation. The cointegrated vectors are formed by recombination of the final vectors (corn expression vectors) with PHP10523, through the COS recombination sites contained in each vector. The cointegrated vectors contain, apart from the expression cassettes described in Examples 14A-C, the genes required by the Agrobacterium strain and the transformation mediated by Agrrojacterium, (TET, TET, TRFA, ORI terminator, CTL, ORI V, VIR Cl , VIR C2, VIR G, VIR B). The transformation into a corn line can be performed as described in Example 13.
Example 15
Preparation of target vectors PHP23236 and PHP29635 for the transformation of corn lines derived from Gaspe Bay Flint
The target vector PHP23236 (sec.with ident number: 6) was obtained by transforming Agrobacterium strain LBA4404 containing plasmid PHP10523 (sec.with ident.ID .: 7) with PHP23235 plasmid (sec. Ident. no .: 8) and isolation of the resulting cointegrate product. The target vector PHP23236 can be used in a recombination reaction with an input clone, as described in Example 16, to create a corn expression vector for the transformation of corn lines derived from Gaspe Bay Flint. The expression of the gene of interest is under the control of the ubiquitin promoter (sec.with ident number: 59).
PHP29635 (sec. With ID No. 13) was obtained by transforming Agrobacterium strain LBA4404 containing PHP10523 plasmid with PIIOXS2a-FRT87 plasmid (ni) m (sec. With ident. No .: 57) and isolation of the resulting cointegrated product. The target vector PHP29635 can be used in a recombination reaction with an input clone, as described in Example 16, to create a corn expression vector for the transformation of corn lines derived from Gaspe Bay Flint. The expression of the gene of interest is under the control of the S2A promoter (sec.with ident.ident .: 60).
Example 16
Preparation of plasmids for the transformation of corn lines derived from Gaspe Bay Flint
With the use of Invitrogen ™ Gateway® recombination technology, entry clones containing the rep2 gene of Arabidopsis (AT5G19590) or a maize-like rep2-like homolog can be created, as described in Examples 5A and 9 and can be used to addressally clone each gene in a target vector PHP23236 (Example 15) for expression under the ubiquitin promoter or in a target vector PHP29635 (Example 15) for expression under the S2A promoter. Each of the expression vectors are binary T-DNA vectors for transformation mediated by Agrrojbacteum in corn.
Corn lines derived from Gaspe Bay Flint can be transformed with the expression constructs as described in Example 17.
Example 17
Transformation of corn lines derived from Gaspe Bay
Flint with validated Arabidopsis guide genes and corresponding homologs from other species
Corn plants can be transformed as described in Example 16 to overexpress the Arabidopsis AT5G19590 gene and the corresponding homologs of other species, such as those listed in Table 1, to examine the resulting phenotype. In addition to the promoters described in Example 16, other promoters, such as the S2B promoter, the corn R00TMET2 promoter, the corn Cyclo, the CR1BI0, the CRWAQ81 and the corn ZRP2.4447 are useful for directing the expression of the rep2 gene. and genes similar to rep2 in corn. In addition, a variety of terminators, such as, but not limited to, the PINII terminator, can be used to achieve expression of the gene of interest in corn lines derived from Gaspe Bay Flint.
Receiving plants
The cells of recipient plants can be of a uniform corn line with a short life cycle ("fast cycle"), of reduced size and of high transformation potential. Typical of these plant cells for corn are the plant cells of the Gaspe Bay Flint (GBF) varieties of lines available to the public. A possible variety of lines of candidate plants is the hybrid Fl of GBF x QTM (Quick Turnaround Maize, a publicly available form of Gaspe Bay Flint, selected for growth under greenhouse conditions) described in Tomes et al. , United States Patent Application Publication No. 2003/0221212. The transgenic plants obtained from this line are of such reduced size that they can be grown in 10.2 cm (four inches) pots (1/4 of the space needed for a normal-sized maize plant) and mature in less than 2.5 months. (Traditionally, it takes 3.5 months to obtain T0 transgenic seeds once the transgenic plants are acclimated to the greenhouse.) Another suitable line is a double haploid X Gaspe Flint line from GS3 (a highly transformable line). Another suitable additional line is an endogamous line of transformable elite that carries a transgene that causes flowering, reduced stature, or both.
Transformation protocol
Any suitable method can be used to introduce the transgenes into the corn cells, including, but not limited to, the inaction type procedures with the use of Agrojbacterium-based vectors as described in Example 9. The transformation can be performed in immature embryos of the recipient plant (objective).
Precision culture and monitoring of the plants The event population of the transgenic plants (T0) resulting from the transformed maize embryos is grown in a controlled greenhouse environment with the use of a modified randomized block design to reduce or eliminate the error environmental. A randomized block design is a plant presentation where the experimental plants are divided into groups (for example, thirty plants per group) called blocks and each plant is randomly assigned a location with the block.
For a group of thirty plants, twenty-four experimental plants, transformed and six control plants (plants with an established phenotype) (collectively, a "group of replicas") are placed in pots arranged in rows (also known as a group of replicas). or blocks) in a table located inside the greenhouse. Each plant, control or experiment, is randomly assigned to a locality with the block drawn to the location of a physical and unique greenhouse, as well as to the group of replicas. Multiple replica groups of thirty plants each can be grown in the same greenhouse in a single experiment. The presentation (arrangement) of the replica groups should be determined to minimize the space requirements, as well as the environmental effects within the greenhouse. Such a presentation may be referred to as a compressed greenhouse presentation.
An alternative to the addition of a specific control group is to identify the transgenic plants that do not express the gene of interest. A variety of techniques, such as TI-PCR, can be applied to quantitatively analyze the level of expression of the introduced gene. The T0 plants that do not express the transgene can be compared with those that express it.
Each plant in the event population is identified and monitored throughout the evaluation process and the information collected from that plant is automatically associated with that plant, so that the information collected can be associated with the transgene transported by the plant. For example, each plant container may have a computer-readable label (such as a barcode of the Universal Product Code (UPC)) that includes the identity information of the plant, which It correlates with a locality in the greenhouse, so that the information obtained from the plant can be automatically associated with that plant.
Alternatively, any machine-readable and efficient plant identification system, such as two-dimensional array codes or even radio frequency identification (RFID) tags, where the information is received and interpreted by an operator can be used. receiver / radiofrequency processor. See United States published patent application no. 2004/0122592, incorporated herein by reference.
Phenot peak analysis with the use of three-dimensional images
Each greenhouse plant in the T0 event population, including any control plant, is analyzed for the agronomic characteristics of interest and the agronomic information for each plant is recorded or stored in such a way that it is associated with information that identifies it (see above) The confirmation of a phenotype (effect of the genes) can be obtained in the TI generation with an experimental design similar to the one described above.
TO plants are analyzed at the phenotypic level with the use of quantitative and non-destructive imaging technology through the complete greenhouse life cycle of the plants to analyze the strains of interest. Preferably, a digital image analyzer is used for multidimensional and automatic analysis of whole plants. Obtaining images can be done inside the greenhouse. To see the plant from all sides, two camera systems placed on top and side are used, as well as an apparatus to turn the plant. The images are obtained from the top, front and side of each plant. The three images together provide enough information to examine the biomass, size and morphology of each plant.
Due to the change in the size of the plants from the moment the first leaf of the soil appears until the moment in which the plants are at the end of their development, the early stages of the development of the plant are documented in the best way with a higher magnification from the top. This can be achieved with the use of a motorized approach lens system controlled entirely by an imaging program.
In a single image analysis operation, the following events occur: (1) the plant is carried inside the analyzer area, rotated 360 degrees so that its readable label for the computer can be read and left to rest until its leaves stop moving; (2) the lateral image is taken and entered into a database; (3) the plant is turned 90 degrees and again allowed to stand until its leaves stop moving and (4) the plant is removed from the analyzer.
The plants are left at least six hours in the dark for a period of twenty-four hours so that they have a normal day / night cycle.
Instrumentation of images
Any type of imaging instrumentation can be used, including, but not limited to, digital spectrum instrumentation of light spectrum commercially available from LemnaTec GmbH of urselen, Germany. The images are taken and analyzed with a LemnaTec Scanalyzer HTS LT-0001-2 with an IT Progressive image device IEE 1/2"CCD. The imaging cameras can be equipped with motorized approach, motorized aperture and motorized focus. The entire configuration of the camera can be realized with the use of the LemnaTec program Preferably, the instrumental variation of the image analyzer is less than about 5% for major components and less than about 10% for minor components.
Programs
The image analysis system comprises a LemnaTec HTS Bonit computer program for color and architecture analysis and a server data base to store data from approximately 500,000 analyzes, including the dates of analysis. The original images and analyzed images are stored together to allow the user to reanalyze as much as they want. The database can be connected to the image hardware for automatic data collection and storage. A wide variety of commercially available program systems (eg, Matlab and others) can be used for the quantitative interpretation of image data, as well as any of these program systems for application to the image data set.
Conveyor system
A conveyor system with a rotating device of plants can be used to transport the plants to the image area and rotate them during the obtaining of the images. For example, up to four floors, each with a maximum height of 1.5 m, are placed on trolleys to pass over the circular conveyor system and the image measurement area. In this case, the total footprint of the unit (image analyzer and conveyor loop) is approximately 5 m x 5 m.
The conveyor system can be enlarged to accommodate more plants at a time. The plants are transported along the conveyor loop to the image area and analyzed up to 50 seconds per plant. The views of the plant are taken. The conveyor system, as well as the imaging equipment, should be able to be used under greenhouse environmental conditions.
illumination
Any suitable lighting mode can be used to capture images. For example, you can use a light on the top on a black background. Alternatively, a combination of upper and rear light can be used with a white background. The illuminated area must be enclosed to ensure constant lighting conditions. The housing must be larger than the measurement area so that constant lighting conditions prevail without opening, closing or doors. Alternatively, the illumination can be varied to cause activation of either the transgene (eg, green fluorescent protein (GFP), red fluorescent protein (RFP)) or endogenous fluorophores ( for example, chlorophyll).
Calculation of the mass based on three-dimensional images
For the best calculation of the biomass, the images of the plant should be taken at least in three-axis views, preferably, the top view and two side views (sides 1 and 2). Then these images are analyzed to separate the plant from the bottom, from the pot and from the pollen control bag (if applicable). The volume of the plant can be calculated by calculating:
Volume (voxels) = - Upper area (pixels) x -Joint of side I (pixels) x -Joint of side 2 (poles)
In the previous equation the units of volume and area are
"arbitrary units". The arbitrary units are completely sufficient to detect genetic effects on the size and growth of the plants in this system, since what is desired is to detect the differences (both the positive and negative-negative ones) of the experimental environment or the environment. control. Arbitrary size units (for example, the area) can be converted trivially into physical measurements by adding a physical reference to the image process. For example, a physical reference of known area can be included both in the process of superior images and in that of lateral images. Based on the area of these physical references, a conversion factor can be determined to allow the conversion of pixels to an area unit such as square centimeters (cm2). The physical reference may or may not be an independent sample. For example, the pot, with a known diameter and height, could serve as an adequate physical reference.
Color classification
Image technology can also be used to determine the color of the plant and to assign the colors of the plants to various kinds of color. The color assignment of the images to the color classes is a characteristic of the LemnaTec program. With other systems of image analysis programs, color classification can be determined by a wide variety of computational approaches.
For the determination of the parameters of the size and growth of the plants, a useful classification scheme is presented to define a simple color scheme that includes two or three green degradations and, additionally, a color class for chlorosis, necrosis and whitening , should these conditions occur. A kind of background color is also used that includes colors in the non-plant image (for example, colors of pots and soil) and these pixels are specifically excluded from the determination of size. The plants are analyzed under constant controlled lighting so that no change can be quantified within a plant over time or between plants or different lots of plants (for example, temporary differences).
In addition to its usefulness in determining the growth of the plant, the color classification can be used to analyze other features of the production component. For these other features of the production component, additional schemes of color classification can be used. For example, the trait known as "always green" that has been associated with improvements in production, can be analyzed by the color classification that separates the green degradations from the shades of yellow and brown (which are indicative of senescent tissues) . If this color classification is applied to the images taken towards the end of the life cycle of the T0 or TI plants, plants with increased amounts of green colors in relation to the yellow or brown colors (expressed, for example, can be identified). , as a green / yellow relation). Plants with a significant difference in this green / yellow ratio can be identified as carrier transgenes that impact this important agronomic trait.
The plant biologist will recognize that other plant colors emerge that may indicate plant health or stress response (eg, anthocyanin) and that other color classification schemes may provide additional measures of genetic action in traits related to these answers .
Analysis of the architecture of the plant
Transgenes that modify the parameters of the architecture of the plant can also be identified with the use of the present invention, including parameters such as maximum height and width, internodal distances, angle between the leaves and the stem, number of leaves arising of the nodules and length of the leaves. The LemnaTec system program can be used to determine the architecture of the plant as follows. The plant is reduced to its main geometric architecture in a first stage of images and then, based on this image, the parametrized identification of the different architecture parameters can be performed. Transgenes that modify any of these architecture parameters, either alone or in combination, can be identified by applying the statistical approaches described above.
Date of pollen spreading
The date of pollen spreading is an important parameter to analyze in a transformed plant and can be determined by the first appearance in the plant of an active male flower. To find the element of the male flower, the upper end of the stem is classified by color to detect yellow or violet anthers. This analysis of the color classification is then used to define an active flower, which in turn can be used to calculate the date of pollen scattering.
Alternatively, the pollen spreading date and other attributes of the plant that are visually detected easily (for example, the date of pollination, date of the first silk) can be recorded by the personnel responsible for the care of the plant. To maximize the integrity of the data and the efficiency of the process, this information is monitored by using the same bar codes used by the digital spectrum analysis device of LemnaTec. A computer with a barcode reader, a digital personal help device or a portable computer can be used to facilitate data capture by recording the observation hours, the plant identifier and the operator that captured the data.
Orientation of the plants
Mature corn plants grown at densities approaching commercial sowing usually have a flat architecture. That is, the plant has a clearly observable wide side and a narrow side. The image of the plant is determined by the wide side. For each plant a well-defined basic orientation is assigned to obtain the maximum difference between the wide side and the side images. The upper image is used to determine the main axis of the plant and an additional rotating device is used to position the plant in the proper orientation before starting the main image acquisition.
Example 18
Screening of corn lines and hybrids derived from Gaspe Bay Flint under nitrogen limiting conditions
Some transgenic plants will contain two or three doses of Gaspe Flint-3 with a dose of GS3 (GS3 / (Gaspe-3) 2X or GS3 / (Gaspe-3) 3X) and will segregate 1: 1 for a dominant transgene. Other transgenic plants are regular inbreds and are used at higher crosses to generate hybrid test plants. The plants will be planted in Turface, a commercial medium for pots and they will be watered four times each day with growth medium of 1 mM KN03 and growth medium of 2 mM K 03 or more (Fig. 3). Control plants grown in 1 mM KN03 medium are less green, produce less biomass and have a smaller spike in anthesis. The lines derived from Gaspe are cultivated until the flowering stage, while the regular inbred and hybrid ones are cultivated until stage V4 to V5.
The statistics are used to decide if the observed differences between treatments are significantly different. Figure 18 illustrates a method that places letters after the values. Values in the same column that have the same letter afterwards (not group of letters) are not significantly different. With the use of this method, if there are no letters after the values in a column, then there are no significant differences between any of the values in that column or, in other words, all the values in that column are the same.
The expression of a transgene will result in plants with improved growth at 1 mM of K 03 when compared to a transgenic null. In this way, the biomass and greenness data will be collected at the time of sampling (antepene for Gaspe and V4-V5 for others) and compared to a transgenic zero. In addition, the total nitrogen in the plants will be analyzed in crushed tissues. Improvements in growth, greenness, nitrogen accumulation and spike size in anthesis will be indicators of the efficiency in the use of increased nitrogen.
Example 19
Analysis of production of corn lines with the validated Arabidopsis guide gene (AT5G19590)
A recombinant DNA construct containing a validated Arabidopsis gene can be introduced into a corn line, either by direct transformation or introgression from a separately transformed line.
Transgenic plants, either endogamous or first-crossing hybrids, may undergo vigorous field experiments to study yield enhancement and / or stability under various environmental conditions, such as variations in water and nutrient availability. A standardized performance test will typically include 4 to 6 replications, and at least 4 locations. The combined data of harvest yield will be collected.
Subsequent yield analysis can be performed to determine if plants containing the validated Arabidopsis guiding gene have an improvement in production yield under various environmental conditions, when compared to the control plants, a null or wild-type construct, which they do not contain the validated Arabidopsis guide gene. The reduction in performance can be measured for both in the case of water stress or nitrogen environments. Plants containing the validated Arabidopsis guiding gene have less loss of production relative to the control plants, preferably 50% less production loss.
Example 20
Screening of corn lines derived from Gaspe Bay Flint under nitrogen-limiting conditions
The transgenic plants will contain two or three doses of Gaspe Flint-3 with a dose of GS3 (GS3 / (Gaspe-3) 2X or GS3 / (Gaspe-3) 3X) and will segregate 1: 1 for a dominant transgene. The plants will be planted in Turface, a commercial medium for pots and they will be watered four times each day with growth medium of 1 mM of K 03 and with growth medium of 2 mM of K 03 or more (see Fig. 3). Control plants growing in KN031 mM medium will be less green, produce less biomass and have a smaller spike in the anthesis (see Fig. 4 for an illustration of the sample data).
The statistics are used to decide if the differences observed between the treatments are really different. Figure 18 illustrates a method that places letters after the values. Values in the same column that have the same letter afterwards (not group of letters) are not significantly different. With the use of this method, if there are no letters after the values in a column, then there are no significant differences between any of the values in that column or, in other words, all the values in that column are the same.
The expression of a transgene will result in plants with improved growth at 1 mM of K 03 when compared to a transgenic null. Thus, biomass and greenery (as described in Example 17) will be monitored during growth and compared to a transgenic zero. The improvements in the growth, greenness and size of the spike in anthesis will be indicators of increased nitrogen tolerance.
Example 21
Analysis of production of corn lines with the validated Arabidopsis guide gene (AT5G19590)
A recombinant DNA construct containing a validated Arabidopsis gene can be introduced into a corn line, either by direct transformation or introgression from a separately transformed line.
Transgenic plants, either inbred or hybrid, can undergo vigorous field experiments to study the enhancement of production and / or stability under various environmental conditions, such as variations in water and nutrient availability.
Subsequent production analysis can be performed to determine if plants containing the validated Arabidopsis guide gene have an improvement in production yield under various environmental conditions, when compared to control plants that do not contain the Arabidopsis guiding gene. validated The reduction in production can be measured for both. Plants containing the validated Arabidopsis guiding gene have less loss of production relative to the control plants, preferably 50% less production loss.
Example 22
Tests to determine alterations in the radicular architecture in corn
Transgenic maize plants are analyzed to identify changes in the radicular architecture at the seedling stage, at the time of flowering or maturity. Tests to measure alterations in the radicular architecture of corn plants include, but are not limited to, the methods described below. To facilitate manual or automated testing of alterations in root architecture, corn plants can be grown in empty pots.
1) Root mass (dry weights). The plants are grown in Turface, a growing medium that allows easy separation of the roots. The tissues of shoots and roots that are dried in the oven are weighed and a root / shoot ratio calculated.
2) Branching levels of lateral roots. The degree of branching of the lateral roots (for example, the number of lateral roots, the length of the lateral roots) is determined by sub-sampling a complete root system, obtaining images with a flatbed scanner or a digital camera and the analysis with the WinRHIZO ™ program (Regent Instruments Inc.).
3) Measurements of the width of the radicular band. The root band is the band or mass of roots that forms at the bottom of greenhouse pots as the plant matures. The thickness of the root band is measured in mm at maturity as an approximate calculation of the root mass.
4) Count of nodal roots. The number of crown roots arising from the upper nodes can be determined after separating the root from the support medium (e.g., seed mix). The angle of the crown roots and / or anchoring roots can also be measured. The digital analysis of the nodal roots and the number of ramifications of the nodal roots form another extension of the manual method mentioned above.
All the data taken from the root phenotype are subject to statistical analysis, usually a t test to compare the transgenic roots with the roots of non-transgenic sister plants. The unidirectional A OVA test can also be used in cases where multiple events and / or constructs are involved in the analysis.
Example 23
Analysis of the roots of maize seedlings containing the rep2 gene of Arabidopsis compared to the roots of seedlings that do not contain the rep2 gene
A corn expression vector, containing the UBI maize promoter and the rep2 (recpu3) gene from Arabidopsis was prepared as described in Example 14A. Corn transformation was achieved through the Agrobacterium-mediated transformation as described in Example 14C by creating a co-integrated vector (PHP30478) and roots were tested by using a seedling assay described in Example 22. 8 events of the PHP30478 construct (ZM-UBI:: AT-RECPU3) were tested in a greenhouse experiment, where 9 plants were grown for each event in Turface medium for stage V4. The seeds were from the TI generation (from the ears collected from the TO plants). The controls in the experiment were plants of the same hybrid corn line, which does not contain the recombinant construct, which grow in the same stage. Seeds were sown with the use of a complete randomized lock design. The plants were harvested 19 days after sowing, when they reached stage V. The roots were washed and collected separately from the shoots. All the samples were oven dried before the dry weights were taken on an analytical balance.
As can be seen in Table 6, it was found that several events have significant changes and all traits measured, when compared to the control.
The analysis of the T test was carried out to show the significant differences between each transgenic event and the control. The p values are shown for each trait: dry root weight, dry shoot weight, and root-to-shoot relationships. Bold values indicate that the transgenic had a higher value than the control. Those with a p-value less than 0.1 were indicated with an asterisk (*).
Table 6
Comparison of transgenic seedlings and control
Event Dry weight of the Dry Weight of the Relationship
root sprout root / sprout
1 SI 0.093 0.041 *
2 0.002 * 0.047 * 0.003 *
Event Dry weight of the Dry Weight of the Relationship
root sprout root / sprout
3 YES YES 0.037
4 0.073 * SI 0.025 *
5 YES YES 0.047 *
6 < 0.001 * < 0.Ó01 * YES
7 YES YES YES
8 0.015 0.003 SI
Total Event DW Nitrogen / weight Dry Total Nitrogen (mg / g) (mg)
1 YES 0.039 * YES
2 0.017 * SI 0.028 *
3 YES < 0.001 * < 0.001 *
4 YES YES NS *
5 SI 0.003 * 0.076 *
6 < 0.001 * 0.003 0.010 *
7 YES YES YES
8 0.004 1 YES YES
Example 24
Performance tests of the transgenic hybrids that grew under normal conditions and conditions with reduced nitrogen in the field.
A field experiment was carried out at two selected sites, one in California (site 1) and the other in Iowa (site 2), in the 2008 season. Ten (10) transgenic events carrying the Arabidopsis REP2 gene (RECPU3) (At5G19590) driven by the UBI promoter of corn, and the controls were included in the experiment. The control consisted of a volcanic non-transgenic void from individual nulls through the 10 events. All the plants were hybrid corn lines generated from a common parental classifier.
Two treatments were applied, consisting of conditions where the plants grow under conditions of "normal" nitrogen or under "reduced" nitrogen conditions. The treatment with nitrogen reduction was carried out in a field where soil nitrogen levels had dropped due to crops planted in previous years without fertilization. The experiments were set as 2-row plots with a density of 32,000 plants per acre. There were 4 replications in the treatment with normal nitrogen and 6 replications in the treatment with reduced nitrogen.
In site 1 under normal treatment, nitrogen fertilizer was applied at a rate of 250 Ib per acre. Treatment with reduced nitrogen received a fertilization of 90 Ib per acre which led to a 13% reduction in yield when compared to treatment with normal nitrogen. The experiments were planted on April 26-28, 2008 and harvested on October 18, 2008.
In site 2, under normal treatment, nitrogen fertilizer was applied at a rate of 260 Ib per acre. Treatment with reduced nitrogen received 60 to 80 Ib per acre of nitrogen fertilization that led to a 6% reduction in yield when compared to normal nitrogen treatment. The experiments were planted on May 15, 2008 and harvested using a harvester. on October 18, 2008.
Grain yield data in bushel per acre of the experiments were summarized as a percentage above zero control, in Table 7. In general, there were 3 events under reduced nitrogen and 7 events under normal nitrogen that had significant increase (indicated by an asterisk). *) in the performance on the voluminous null control (alpha = 0.2, 2-tailed analysis). Most of the events tested showed a positive increase in the production trend over the nulls.
Table 7
Testing of the performance of the transgenics against the control plants under conditions of low and normal nitrogen.
Site Event Performance increase Importance Treatment
On the null
1 1 Little
1. 38% nitrogen
1 2 Little
-1.74% nitrogen
1 3 * Little
6. 26% nitrogen
1 4 Little
2. 30% nitrogen
Site Event Performance increase Importance Treatment On the null
1 5 * Little
6. 30% nitrogen
1 6 Little
2. 47% nitrogen
1 7 Little
1. 70% nitrogen
1 8 * Little
4. 85% nitrogen
1 9 Little
3. 41% nitrogen
1 10 Little
-2.00% nitrogen
1 1 Nitrogen
3. 04% normal
1 2 Nitrogen
1. 87% normal
1 3 * Nitrogen
5. 59% normal
1 4 Nitrogen
2. 28% normal
1 '5 * Nitrogen
5. 16% normal
1 6 * Nitrogen
5. 63% normal Site Event Performance increase Importance Treatment On the null
1 7 Nitrogen
1. 11% normal
1 8 Nitrogen
0. 88% normal
1 9 Nitrogen
-1.88% normal
1 10 Nitrogen
2. 41% normal
2 1 * Nitrogen
8. 87% normal
2 2 * Nitrogen
17. 09% normal
2 3 Nitrogen
Not tested normal
2 4 Nitrogen
Not tested normal
2 5? Nitrogen
10. 86% normal
2 6 * Nitrogen
10. 39% normal
2 7 Nitrogen
4. 02% normal
2 8 Nitrogen
4. 17% normal Site Event Performance increase Importance Treatment On the null
2 9 * Nitrogen
10. 29% normal
2 10 * Nitrogen
4. 09% normal
It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.
Claims (15)
1. A plant comprising in its genome a recombinant DNA construct comprising a polynucleotide operatively linked to at least one regulatory element, characterized in that the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% sequence identity, with based on the Clustal V alignment method, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42 and where the plant shows alteration in the radicular architecture compared to a control plant that does not include the recombinant DNA construct.
2. A plant comprising in its genome a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory element, characterized in that the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% sequence identity, based on the method of Clustal V alignment, when compared to sec. with no. of ident: 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42 and where the plant shows some alteration of at least one agronomic characteristic in comparison with a control plant that does not comprise the recombinant DNA construct.
3. The plant according to claim 2, further characterized in that at least one agronomic characteristic is at least one selected from the group consisting of greenness, yield, growth rate, biomass, fresh weight at maturity, dry weight at maturity, production of fruits, seed production, total nitrogen content in the plant, nitrogen content in the fruits, nitrogen content in the seeds, nitrogen content in a vegetative tissue, total content of free amino acids in the plant, content of free amino acids in the fruits, content of free amino acids in the seeds, content of free amino acids in a vegetative tissue, total content of proteins in the plant, content of proteins in the fruits, content of proteins in the seeds, content of proteins in a vegetative tissue, drought tolerance, nitrogen uptake, root location, stem location, height of p lanta, spike length and harvest index.
4. The plant according to claim 2 or claim 3, characterized in that it exhibits the alteration of at least one agronomic characteristic when compared, under varying environmental conditions, wherein the environmental condition is at least one selected from drought, nitrogen or disease, with the control plant that does not comprise the recombinant DNA construct.
5. The plant according to any of claims 1 to 4, further characterized in that the plant is a corn plant or a soybean plant.
6. A method to alter the radicular architecture in a plant; characterized because it comprises: (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence; wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% sequence identity, based on the Clustal V alignment method, when compared to sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42; (b) regenerating a transgenic plant from the regenerable plant cell after step (a), characterized in that the transgenic plant comprises in its genome the recombinant DNA construct; Y (c) obtaining a progeny plant derived from the transgenic plant of step (b), wherein the progeny plant comprises in its genome the recombinant DNA construct and shows alteration in the radicular architecture when compared to a control plant that does not comprise the recombinant DNA construct.
7. A method to evaluate the altered root architecture in a plant, characterized because it comprises: (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence, the polynucleotide encoding a polypeptide with an amino acid sequence of at least 50% sequence identity, with base in Clustal V alignment method, when compared with sec. with no. of ident. : 15, 17, 19, 21; 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42; Y (b) regenerating a transg plant from the regenerable plant cell after step (a), wherein the transg plant comprises in its genome the recombinant DNA construct; (c) obtaining a progeny plant derived from the transg plant, wherein the progeny plant comprises in its genome the recombinant DNA construct; Y (d) evaluating the progeny for the altered architecture of the root compared to a control plant that does not comprise the recombinant DNA construct.
8. A method for determining an alteration of an agronomic characteristic in a plant, characterized in that it comprises: (a) introducing into a regenerable plant cell a recombinant DNA construct comprising a polynucleotide operably linked to at least one regulatory sequence, wherein the polynucleotide encodes a polypeptide with an amino acid sequence of at least 50% sequence identity , based on Clustal V alignment method, when compared with sec. with no. of ident. : 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 42; Y (b) regenerating a transg plant from the regenerable plant cell after step (a), wherein the transg plant comprises in its genome the recombinant DNA construct; (c) obtaining a progeny plant derived from the transg plant, wherein the progeny plant comprises in its genome the recombinant DNA construct; Y (d) determining whether the progeny plant shows any alteration of an agronomic characteristic as compared to a control plant that does not comprise the recombinant DNA construct.
9. The method according to claim 8, characterized in that the step (d) of determining comprises determining if the transg plant exhibits an alteration of an agronomic characteristic when it is compared, under variable environmental conditions, where the environmental condition is at least one selected of drought, nitrogen, or disease, with the control plant that does not comprise the recombinant DNA construct.
10. The method according to claim 8 or claim 9, characterized in that at least one agronomic characteristic is at least one selected from the group consisting of greenery, yield, growth rate, biomass, fresh weight at maturity, dry weight at maturity, fruit production, seed production, total nitrogen content in the plant, nitrogen content in the fruits, nitrogen content in the seeds, nitrogen content in a vegetative tissue, total content of free amino acids in the plant, content of amino acids free in fruits, content of free amino acids in seeds, content of free amino acids in a vegetative tissue, total content of proteins in the plant, content of proteins in fruits, content of proteins in seeds, content of proteins in a tissue vegetative, drought tolerance, nitrogen uptake, root location, stem location, a plant height, length of the ears and harvest index.
11. The method according to any of claims 6 to 10, characterized in that the plant is a corn plant or a soybean plant.
12. An isolated polynucleotide characterized in that it comprises: (a) a nucleotide sequence encoding a polypeptide similar to REP2 or REP2, wherein based on the Clustal V alignment method, the polypeptide has an amino acid sequence of at least 80% sequence identity, when compared to sec. with no. of ident. : 40, or at least 85% sequence identity, when compared to sec. with no. Ident .: 36 6 38, or at least 95% sequence identity, when compared to sec. with no. of ident. : 16 or 32, or the amino acid sequence comprises sec. with no. of ident. : 16, 32, 36, 38 or 40; or (b) the complete complement of the nucleotide sequence of (a).
13. The polynucleotide according to claim 12, characterized in that the amino acid sequence of the polypeptide comprises sec. with no. of ident. : 16, 32, 36, 38 or 40
14. The polynucleotide according to claim 12, characterized in that the nucleotide sequence comprises sec. with no. Ident .: 16, 32, 36, 38 or 40.
15. A plant or seed comprising a recombinant DNA construct, characterized in that the recombinant DNA construct comprises the polynucleotide of any of claims 12 to 14 operably linked to at least one regulatory sequence.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8328808P | 2008-07-24 | 2008-07-24 | |
| PCT/US2009/051665 WO2010011907A2 (en) | 2008-07-24 | 2009-07-24 | Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011000780A true MX2011000780A (en) | 2011-03-15 |
Family
ID=41059541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011000780A MX2011000780A (en) | 2008-07-24 | 2009-07-24 | Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2326663A2 (en) |
| CN (1) | CN102131824A (en) |
| BR (1) | BRPI0911739A2 (en) |
| CA (1) | CA2729099A1 (en) |
| MX (1) | MX2011000780A (en) |
| RU (1) | RU2011106766A (en) |
| WO (1) | WO2010011907A2 (en) |
| ZA (1) | ZA201009172B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109112135B (en) * | 2017-06-28 | 2021-01-12 | 华中农业大学 | Application of OsREP4 gene in controlling drought resistance of rice |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060150283A1 (en) * | 2004-02-13 | 2006-07-06 | Nickolai Alexandrov | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| US20070277269A1 (en) * | 2006-04-17 | 2007-11-29 | Ceres, Inc. | Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| WO2007124312A2 (en) * | 2006-04-19 | 2007-11-01 | Pioneer Hi-Bred International, Inc. | Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use |
-
2009
- 2009-07-24 BR BRPI0911739A patent/BRPI0911739A2/en not_active IP Right Cessation
- 2009-07-24 EP EP09790798A patent/EP2326663A2/en not_active Withdrawn
- 2009-07-24 WO PCT/US2009/051665 patent/WO2010011907A2/en not_active Ceased
- 2009-07-24 MX MX2011000780A patent/MX2011000780A/en not_active Application Discontinuation
- 2009-07-24 RU RU2011106766/10A patent/RU2011106766A/en not_active Application Discontinuation
- 2009-07-24 CN CN2009801289798A patent/CN102131824A/en active Pending
- 2009-07-24 CA CA2729099A patent/CA2729099A1/en not_active Abandoned
-
2010
- 2010-12-21 ZA ZA2010/09172A patent/ZA201009172B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102131824A (en) | 2011-07-20 |
| WO2010011907A2 (en) | 2010-01-28 |
| ZA201009172B (en) | 2012-03-28 |
| BRPI0911739A2 (en) | 2019-03-06 |
| EP2326663A2 (en) | 2011-06-01 |
| RU2011106766A (en) | 2012-08-27 |
| WO2010011907A3 (en) | 2010-03-18 |
| CA2729099A1 (en) | 2010-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2527449A2 (en) | Methods involving genes encoding nucleoside diphosphatase kinase (NDK) polypeptides and homologs thereof for modifying the plant's root architecture | |
| US20090044293A1 (en) | Plants with altered root architecture, involving the rt1 gene, related constructs and methods | |
| WO2011053897A1 (en) | Drought tolerant plants and related constructs and methods involving genes encoding dtp21 polypeptides | |
| US20110138501A1 (en) | Plants with altered root architecture, related constructs and methods involving genes encoding protein phophatase 2c (pp2c) polypeptides and homologs thereof | |
| US20150284739A1 (en) | Drought tolerant plants and related constructs and methods involving genes encoding ferrochelatases | |
| US8338181B2 (en) | Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding LNT2 polypeptides and homologs thereof | |
| WO2010006010A1 (en) | Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt1 polypetides and homologs thereof | |
| US20140245497A1 (en) | Drought tolerant plants and related constructs and methods involving genes encoding ferredoxin family proteins | |
| US20110314570A1 (en) | Drought tolerant plants and related constructs and methods involving genes encoding zinc-finger (c3hc4-type ring finger) family polypeptides | |
| US20120004114A1 (en) | Nucleotide sequences encoding gsh1 polypeptides and methods of use | |
| US20140007298A1 (en) | Plants with altered root architecture, related constructs and methods involving genes encoding protein phophatase 2c (pp2c) polypeptides and homologs thereof | |
| CA2703151A1 (en) | Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof | |
| US20110035837A1 (en) | Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt3 polypeptides | |
| MX2011004443A (en) | Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof. | |
| MX2011000780A (en) | Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof. | |
| CA2775563A1 (en) | Drought tolerant plants and related constructs and methods involving genes encoding self-incompatibility protein related polypeptides | |
| MX2011006419A (en) | Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt9 polypeptides. | |
| US20120047603A1 (en) | Drought tolerant plants and related constructs and methods involving genes encoding fatty acid desaturase family polypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |